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ABSTRACT
NEUROMUSCULAR FUNCTION IN ACHILLES TENDINOPATHY

Lauren K. Sara, DPT
Marquette University, 2021

Midportion Achilles tendinopathy (AT) is a chronic, painful condition of the
long tendon that attaches the triceps surae muscle group (the soleus, medial and
lateral gastrocnemius muscles), which are the primary plantar flexor muscles, to
the calcaneus bone. There is incomplete understanding of the underlying
pathophysiology, pain, and role of plantar flexor function (strength and
fatigability) in functional impairment in AT. Deficits in plantar flexor muscle
function are assumed, but evidence is sparce and inconclusive. There is no
understanding of whether people with AT have deficits in neural drive to the
plantar flexor muscles or altered contractile function, or the role of pain in
mediating plantar flexor function in AT. The purpose of this dissertation was to
evaluate plantar flexor muscle function both in persons with AT compared to
healthy controls and during a common clinical test, the Single-Leg Heel Raise.
The Single-Leg Heel Raise test (SLHR) is purported to measure plantar
flexor muscle strength. Study 1 challenged this notion by comparing performance
in this task to the torque produced during a maximal voluntary isometric
contraction, a validated test for measuring maximal strength. The lack of
associations between task performance and maximal strength suggests that the
SLHR is not an indicator of maximal plantar flexor strength, but rather a measure
of muscular endurance.
Deficits in plantar flexor strength, power and fatigability are assumed in
persons with AT. Studies 2 and 3 investigated this assumption by measuring
maximal isometric, and dynamic plantar flexor strength, SLHR repetitions, and
isometric fatigability in AT and controls. There were no strength or fatigability
differences between groups. However, contractile function was less in people
with AT, and this was correlated with pain in the Achilles tendon.
Despite similar task performance, including plantar flexor strength and
fatigability, contractile function may be impaired in AT, perhaps a result of pain
mechanisms. Rather than emphasizing maximal strength and fatigability alone,
an integrated approach, including interventions that address both chronic pain
and impaired plantar flexor contractility, are necessary when treating people with
AT.

i
ACKNOWLEDGEMENTS

Lauren K. Sara, DPT

Completion of this doctoral dissertation relied upon contributions from
several individuals. Whether physical assistance with study design and data
collection, expertise in technical and writing skills, feedback on writing and
publications, or psychosocial and emotional support, I am extremely grateful to
all who contributed, in one form or another, to this work.
I must first thank my dissertation advisor, Professor Sandra Hunter. In
addition to overseeing my dissertation research, Professor Hunter taught me how
to be a researcher. In all aspects of my research journey, she empowered me to
just “go for it,” rather than letting my novice status limit my endeavors. She
encouraged me as I navigated through grant submissions, study design, and
data collection, and she was meticulous in providing feedback on drafts of my
presentations and manuscripts. Importantly, she was a fierce supporter of me
and my work, which is an incredibly powerful message to send to a trainee.
Finally, I truly enjoyed the time I spent in her physical and virtual office space,
whether discussing research, life, or matters of the world. I am so grateful for the
relationship we developed during my tenure as her doctoral student.
Additionally, I am grateful for the service provided by the other four
members of my dissertation committee: Professors Donald Neumann and Marie
Hoeger Bement and Drs. Karin Silbernagel and Craig Young. I am especially
appreciative of their willingness to take time out of their busy schedules to mentor
me throughout this endeavor. Each of these members provided unique expertise
to the project, helping sculpt it into a well-rounded project that encompasses
many diverse variables.
I owe an immense thank you to Professor Donald Neumann. In addition to
serving on my dissertation committee, Professor Neumann has served as a sort
of career mentor for me. He has been an extraordinary source of support
throughout my career, from serving as my academic advisor during physical
therapy school to guiding me throughout this important first step in my academic
career. Importantly, Professor Neumann has empowered me in a way no one
else has; this began as invitations to review his academic papers but grew into
opportunities to collaborate on his textbook and serve as a guest lecturer in his
kinesiology course. His ongoing support continues to propel me forward, and I
cannot thank him enough for continuing to empower me even when it feels
undeserved.

ii
To my undergraduate research assistants, many of whom continued to
support my work during their tenure in physical therapy school, I owe an
enormous thank you: Savannah (Hickock) Gutsch, Karis Yang, Lizzie Clements,
Meggie Rose Hart, Monica Geisser, and Michael Hendrickson. The data
collection and analysis involved in these research projects would simply not have
been possible without their help.
I also wish to thank Dr. Kathleen Lukaszewicz for her dedication to the
graduate students in the Exercise and Rehabilitation Sciences program. Her
organization and attention to detail made the administrative portion of this degree
much more manageable. She is also a fierce advocate for her students,
proposing and instituting changes based on their input and experiences. Thank
you, Dr. Luke.
I am fortunate to have been able to tap into the expertise of so many
during my studies. Thank you to the many great minds within the Physical
Therapy Department and beyond, who took particular interest in my project,
encouraged me in this endeavor, and provided guidance on a number of topics.
These individuals include: Professors Alex Ng, Lawrence Pan, and Allison
Hyngstrom; Drs. Kristof Kipp, Sheila Schindler-Ivens, Andrew Starsky and Frank
DiLiberto. A special thank you also to Professor Guy Simoneau, Tony Hornung,
and Jeremy Karman for encouraging me and providing their expertise throughout
my journey, as early as physical therapy school and continuing to this day. I
would also like to thank members of Professor Bement’s pain lab for lending their
time and expertise toward pain-related aspects of study design: Drs. Ali
Alsouhibani, Abdulaziz Awali, and Giovanni Berardi. I also wish to thank the
many people who made scheduling, budgeting, room reservation, and other
logistical issues easier: Michelle Raclawski, Diane Slaughter, Bonnie SchlinderDelap, Toni Urich, Cynthia Swiatlowski, Memory Bacon, Yolanda Webb, and
Melissa Kading.
I owe additional thanks to current and past graduate students and
postdoctoral fellows who have trained in Professor Hunter’s lab: Drs. Timothy
Fulton, Christopher Sundberg, Minhyuk Kwon, Rita Deering, and Jonathan
Senefeld; Blaine Arney, Kevin Ryan, Mitch Adam, Sarah D’Astice, and Jose
Delgadillo. Thank you for your advice, inspiration, encouragement, and
friendship. It has been a pleasure to grow with you and learn from you.
Earning a Doctor of Philosophy is an exceptionally humbling and
oftentimes isolating experience. Fortunately, I had many people supporting me
emotionally and psychologically during this entire process. These people helped
make this process a little less isolating. They encouraged me, comforted me, and
celebrated alongside me. To these people, I owe a debt of gratitude. Specifically,
I wish to thank my parents, John and Joan, and sisters, Leslie and Kelli, for
supporting me long before I even started this journey and for continuing to

iii
believe in me. Thanks also to my husband’s family for taking interest in my work
and cheering me along the whole way: Jane and Paul; Jim and Ginny; and Mike.
Finally, a huge thank you to my husband, Brian Sara, for standing beside me
during this entire process. Brian has been the best supporter I could ask for: he is
a constant source of encouragement, a listening ear, a second set of eyes, and
the person who always made sure I took a moment to celebrate my
achievements. Thank you, Brian, for believing in me.

iv
TABLE OF CONTENTS
ACKNOWLEDGEMENTS ..................................................................................... I
LIST OF TABLES ............................................................................................... IX
LIST OF FIGURES ............................................................................................... X
CHAPTER 1 INTRODUCTION & REVIEW OF LITERATURE............................. 1
Anatomy & Physiology of the Achilles Tendon and Triceps Surae ............ 3
Strength, Power & Fatigability .................................................................... 7
Strength .......................................................................................... 7
Power & Work ................................................................................. 8
Fatigability ....................................................................................... 8
Resting Twitch Torque: a Measure of Contractile Mechanisms ...... 9
Voluntary Activation: a Measure of Neural Drive ............................. 9
Pain Perception ....................................................................................... 10
Pathophysiology of Midportion Achilles Tendinopathy ............................. 11
Nomenclature & the Roles of Inflammation and Degeneration in
Tendon Pathology ......................................................................... 11
Signs, Symptoms, & Onset in Midportion Achilles Tendinopathy............. 14
Incidence & Prevalence ................................................................ 15
Predisposing Factors in Midportion Achilles Tendinopathy ........... 15
Sex Differences in Midportion Achilles Tendinopathy ................... 16
Pain & Neurovascular Considerations........................................... 16
Strength & Fatigability in Achilles Tendinopathy ...................................... 19
Clinical Evaluation of Plantar Flexor Function ............................... 21
Clinical Interventions for Chronic Midportion Achilles Tendinopathy
...................................................................................................... 23

v
Specific Aims ........................................................................................... 24
CHAPTER 2 : THE SINGLE-LEG HEEL RAISE TEST ..................................... 28
Introduction .............................................................................................. 28
Materials & Methods ................................................................................ 31
Participants ................................................................................... 31
Experimental Setup ....................................................................... 32
Baseline Measures........................................................................ 32
Single-leg heel raise task .............................................................. 34
Post SLHR Task Measurements ................................................... 35
Electromyography (EMG) .............................................................. 36
Data and Statistical Analyses ........................................................ 36
Results ..................................................................................................... 38
SLHR and MVIC............................................................................ 39
EMG .............................................................................................. 41
Voluntary Activation and Twitch Amplitude ................................... 42
Associations .................................................................................. 43
Discussion ............................................................................................... 44
Fatigability and Strength ............................................................... 45
Mechanisms .................................................................................. 47
Limitations ..................................................................................... 50
Conclusions .................................................................................. 52
Clinical Relevance......................................................................... 52
CHAPTER 3 : PLANTAR FLEXOR STRENGTH IN ACHILLES
TENDINOPATHY ............................................................................................... 54
Introduction .............................................................................................. 54
Materials & Methods ................................................................................ 57

vi
Participants ................................................................................... 57
Experimental Setup ....................................................................... 58
Baseline Measures........................................................................ 59
Pressure-Pain Thresholds ............................................................. 61
Isometric Strength, Voluntary Activation and Contractile Properties
...................................................................................................... 63
Dynamic Strength.......................................................................... 64
Data and Statistical Analyses ........................................................ 64
Results ..................................................................................................... 66
Subjects ........................................................................................ 66
Self-Reported Pain and Disability.................................................. 67
Isometric Plantar Flexor Strength .................................................. 67
Dynamic Strength & Power of the Plantar Flexor Muscles ............ 68
Voluntary Activation & Contractile Function .................................. 72
Pain ............................................................................................... 73
Predictors of Isometric MVC Strength ........................................... 74
Discussion ............................................................................................... 75
Strength in AT ............................................................................... 76
Neural and Muscular Factors in AT ............................................... 77
Pain Pressure Thresholds in AT.................................................... 78
Limitations ..................................................................................... 80
Conclusions .................................................................................. 81
CHAPTER 4 : PLANTAR FLEXOR FATIGABILITY IN ACHILLES
TENDINOPATHY ............................................................................................... 83
Introduction .............................................................................................. 83
Materials & Methods ................................................................................ 85

vii
Participants ................................................................................... 85
Single-Leg Heel Raise .................................................................. 86
Isometric Fatiguing Exercise Task: Experimental Setup ............... 87
Perceived Pain and Exertion ......................................................... 89
Pressure-Pain Thresholds ............................................................. 90
Isometric Fatiguing Exercise Task ................................................ 91
Data and Statistical Analyses ........................................................ 92
Results ..................................................................................................... 94
Participants ................................................................................... 94
Fatigability: Single-Leg Hell Raise Test......................................... 95
Fatigability: Isometric Contractions ............................................... 95
Voluntary Activation, and Resting Twitch Amplitude ..................... 96
Pain ............................................................................................... 98
Predictors of Fatigability .............................................................. 102
Discussion ............................................................................................. 104
Summary of Findings .................................................................. 104
Fatigability ................................................................................... 104
Reductions in Neural Drive and Contractile Function as
Mechanisms of Fatigability .......................................................... 105
Effect of Pain on Motor Output .................................................... 106
A Comprehensive Look at Pain and Contractile Function in AT .. 106
Limitations ................................................................................... 108
Conclusions ................................................................................ 109
CHAPTER 5 : CONCLUSIONS & FUTURE DIRECTIONS ............................. 111
Purpose ................................................................................................. 111
Strength & Fatigability Between Groups ................................................ 111

viii
The Single-Leg Heel Raise Test ............................................................ 112
Sex Differences in Plantar Flexor Function ............................................ 114
Bilateral Changes in Muscle Function in AT .......................................... 114
Neural Drive and Contractile Function ................................................... 115
Pain and Its Interactions with Muscle Function in AT ............................. 118
Limitations.............................................................................................. 121
Summary ............................................................................................... 122
Bibliography ........................................................................................... 124

ix
LIST OF TABLES
Table 2.1. Participant demographics & baseline characteristics. ................... 39
Table 3.1. Demographics of the test groups. ................................................... 67
Table 3.2. Peak plantar flexor torque during concentric and eccentric
velocities. ........................................................................................................... 69
Table 3.3. Peak plantar flexor power during concentric and eccentric
velocities. ........................................................................................................... 70
Table 4.1. Demographics of the test groups .................................................... 95

x
LIST OF FIGURES
Figure 2.1. Experimental setup, study protocol, and raw data. ........................... 34
Figure 2.2. Box-and-whisker plot of single-leg heel raise (SLHR) repetitions
performed by males and females. ...................................................................... 40
Figure 2.3. MVIC torque before and after the SLHR in males and females. ....... 41
Figure 2.4. Change in RMS EMG amplitude for each the soleus, medial and
lateral gastrocnemius, and tibialis anterior muscles from the start to end of the
SLHR task, as a percent of baseline MVIC. ....................................................... 42
Figure 2.5 Voluntary activation (A) and resting twitch amplitude (B) before and
after the SLHR task in males and females pooled. ............................................. 43
Figure 3.1. Experimental setup of a participant in the Biodex System3 Pro
dynamometer used for plantar flexor strength measurements. .......................... 60
Figure 3.2. PPT measurement locations. ........................................................... 61
Figure 3.3. Representative torque data from a male participant during maximal
voluntary isometric contraction (isometric MVC)................................................. 63
Figure 3.4. Maximal isometric plantar flexor torque, normalized to body weight. 68
Figure 3.5. Plantar flexor torque-velocity relationship, normalized to body weight.
........................................................................................................................... 71
Figure 3.6. Maximal plantar flexor power at each dynamic velocity, normalized to
body weight. ....................................................................................................... 71
Figure 3.7. Plantar flexor resting twitch amplitude, normalized to body weight, in
people with AT compared to healthy controls. .................................................... 72
Figure 3.8. Voluntary activation of the plantar flexor muscles in people with AT
and healthy controls. .......................................................................................... 73
Figure 3.9. Pressure-pain thresholds (PPTs) at the medial gastrocnemius (MG),
Achilles tendon (AT), and upper trapezius (UT) in AT compared with controls. . 74
Figure 4.1. Representative torque data from a male AT participant during the
intermittent MVIC task. ....................................................................................... 91
Figure 4.2. Fatigability (the reduction in MVIC across time) was not different
between groups (p=0.936).................................................................................. 96

xi
Figure 4.3. All groups demonstrated reductions in neural drive over time
(p=0.006). ........................................................................................................... 97
Figure 4.4. RT was lower in AT compared to controls at all time points (p=0.001).
........................................................................................................................... 98
Figure 4.5. Upper trapezius PPTs were higher in AT compared to controls at all
time points (p=0.011). ....................................................................................... 101
Figure 4.6. Achilles tendon PPTs were not different between groups (p=0.720) or
between limbs (p=0.630). ................................................................................. 101
Figure 4.7. Medial gastrocnemius PPTs were not different between groups
(p=0.615) or between limbs (p=0.695). ............................................................. 102

1
CHAPTER 1 INTRODUCTION & REVIEW OF LITERATURE
Midportion Achilles tendinopathy (AT) is a chronic, painful condition of the
long tendon that attaches the triceps surae muscle group – the soleus, medial
and lateral gastrocnemius muscles – to the calcaneus bone. The estimated
lifetime prevalence of AT is 30% in sedentary individuals and 50% in endurance
athletes (Joseph and Denegar, 2015). The widely accepted mechanism of injury
is overuse of the calf muscle-tendon unit (Martin et al., 2018). However, there is
incomplete understanding of the pathology as it relates to pain and functional
impairment in AT. As a result, current treatment interventions are only
moderately successful, and symptoms can persist for years (Van der Plas et al.,
2012, Silbernagel et al., 2007a, Paavola et al., 2000, Paavola et al., 2002).
Most AT research focuses on the tendon, including histopathologic
investigations (Pearce et al., 2009, de Mos et al., 2009, Burssens et al., 2013),
imaging evaluations (Pingel et al., 2013, Bakkegaard et al., 2015, De Jonge et
al., 2014, Gärdin et al., 2013, Pierre-Jerome et al., 2010), mechanical properties
(Child et al., 2010, Arya and Kulig, 2010, Aubry et al., 2015) and biomechanical
implications for the tendon (Lorimer and Hume, 2016, Intziegianni et al., 2016,
Grigg et al., 2012, Grigg et al., 2013, Dowling et al., 2014, Nuri et al., 2017). In
contrast to the abundance of tendon-centric research in AT, a 2014 systematic
review (Magnan et al., 2014) identified only one study (of 68 included) that
identified muscle strength as a possible predisposing factor in AT. Since that
time, few research studies have addressed plantar flexor muscle function, such
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as muscle strength (isometric or dynamic), power or exercise-induced fatigability
of the muscle in AT.
A systematic review of “muscle function” (which included any studies that
evaluated strength, power, rate of force development, endurance, and work) in
AT was recently completed (Hasani et al., 2021). Their extensive literature review
identified 15 studies that included at least one metric of muscle function in a
heterogeneous population that included both insertional and midportion AT. The
metrics used to quantify muscle function included the following: peak torque
during isometric and dynamic contractions; six repetition maximum; rate of force
development; single-leg hop distance; soleus H-reflex; and power, work, and
repetitions completed during the single-leg heel raise test. Their review found the
available evidence to be conflicting for all measures of muscle function when
comparing healthy controls to individuals with midportion and insertional AT.
When comparing limbs in persons with insertional or midportion AT, evidence
was limited-to-moderate for between-limb differences in maximal torque (greater
impairments of the affected limb) but conflicting for all other measures of plantar
flexor muscle function (including power, endurance, and rate of force
development) (Hasani et al., 2021). The authors emphasized a need for further
research evaluating plantar flexor muscle function in AT.
In addition to conflicting evidence for impaired plantar flexor strength and
power, there is poor understanding of any mechanisms that may underly such
changes in motor output. No studies have yet evaluated the underlying
neuromuscular physiology contributing to any such changes in plantar flexor
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muscle function in persons with AT. This dissertation addresses an important gap
in the literature by determining whether there are deficits in plantar flexor muscle
function (strength, power and fatigability) as they relate to symptoms and function
in persons with midportion AT. This dissertation will also determine whether any
alteration in muscle function with AT is related to neural or muscular
mechanisms. The literature review that follows will incorporate anatomy,
physiology and other relevant considerations that led to the development of the
project Aims.

ANATOMY & PHYSIOLOGY OF THE ACHILLES TENDON AND TRICEPS
SURAE

The functional role of tendon is to transmit force within the musculoskeletal
system (Sara and Neumann, 2017). Human movement is the result of rotational
displacement of bone about a pivot point, the joint. Control of human movement
and posture is achieved through the translation of linear, muscular-produced
force into rotational torque across a joint (Hunter et al., 2017). The intermediary
of this process is tendon: tendon attaches between muscle and bone, passively
propagating force from contractile tissue (muscle) to bone to generate joint
rotation (Sara and Neumann, 2017). In contrast to skeletal muscle, which is
activated by the central nervous system, tendon receives no motor supply from
the central nervous system. Instead, it is a highly elastic tissue that serves to
passively store and release energy and to dissipate forces within the
musculoskeletal system. Unlike skeletal muscle, healthy tendon is largely
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avascular and aneuronal (Ackermann, 2013, Ackermann et al., 2014, Abate et
al., 2009, Bondi et al., 2015).
The Achilles tendon is the strongest and thickest tendon in body (Doral et al.,
2010, Pierre-Jerome et al., 2010). Perhaps paradoxically, it is also one of the
most frequently injured structures of the lower extremities (Joseph and Denegar,
2015). The most common Achilles tendon diagnosis is tendinopathy (Joseph and
Denegar, 2015), a condition plagued by chronicity and resistance to treatment
interventions (Paavola et al., 2000, Paavola et al., 2002). Limited vascular and
neural supply to tendon likely contribute to slow adaptation to loading. This, in
turn, translates to prolonged – and often incomplete – healing (Ackermann et al.,
2009, Abate et al., 2009).
The Achilles tendon connects three muscles, together known as the triceps
surae, to the calcaneus (Neumann, 2017). The triceps surae group consists of
the soleus, medial and lateral gastrocnemii muscles, and the predominant motion
created by these muscles is plantar flexion across the talocrural (ankle) joint.
Seventy to eighty percent of maximal plantar flexor torque is generated by the
triceps surae group (Murray et al., 1978, Belanger and McComas, 1981).
Proximally, the gastrocnemius attaches at the posterior distal femur, while the
soleus attaches along the posterior aspects of the tibia and fibula. Together, the
three muscles insert into the Achilles tendon, ultimately attaching into the
posterior calcaneus (Pierre-Jerome et al., 2010).
The functional importance of the gastrocnemii and soleus muscles is typically
simplified in a binary manner – based on fiber type composition – into that of
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power or endurance. The soleus is comprised of approximately 80% type I (slowtwitch) fibers, which is a fiber type associated with endurance activities
(Schoenfeld et al., 2020, Wilson et al., 2012, Talbot and Maves, 2016, Johnson
et al., 1973). The medial and lateral gastrocnemius are comprised of
approximately 50% type I (slow-twitch) and 50% type II (fast-twitch) fibers
(Schoenfeld et al., 2020, Johnson et al., 1973), the latter of which are associated
with production of power (Fitts et al., 1991, Fitts and Widrick, 1996). The soleus
is, therefore, credited with playing an important endurance role for the triceps
surae group (Fitts and Widrick, 1996) and serving an important postural role for
lower limb stability (Mochizuki et al., 2005). The gastrocnemius muscles, due to
their proportionally greater composition of fast fibers when compared to the
soleus muscle, are associated with power production (Fitts et al., 1991, Fitts and
Widrick, 1996).
Some researchers have proposed that deficits within the soleus are
responsible for the onset of AT (O'Neill et al., 2019, Padhiar et al., 2008). This is
a particularly compelling argument given (1) the preferential atrophy of slowtwitch muscle fibers with decreased loading (Trappe et al., 2008), (2) the
prevalence of AT among endurance exercisers (Kujala et al., 2005), and (3) that
the most common inciting factor in AT is a sudden increase or change in activity
and therefore an increased load on the musculotendon complex. Currently,
however, there is insufficient evidence to conclusively describe unique
contributions of triceps surae muscles to AT pathophysiology.
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As stated previously, the greatest torque contribution to plantar flexion – 7080% – comes from the triceps surae group (Murray et al., 1978, Belanger and
McComas, 1981). This can be attributed to the combination of a large internal
moment arm and large physiologic cross-sectional area of the triceps surae
muscles (Neumann, 2017). The remaining plantar flexor torque generation arises
from the fibularis longus and brevis, flexor hallucis longus, flexor digitorum
longus, plantaris, and tibialis posterior muscles. The antagonist muscles, the
dorsiflexors, include the tibialis anterior, extensor digitorum longus, extensor
hallucis longus, and fibularis tertius (Neumann, 2017).
The triceps surae receives its motor innervation from the tibial nerve, a
branch of the sciatic nerve. Bifurcation of the sciatic nerve commonly occurs at
the superior angle of the popliteal space, where it divides into the tibial and
common fibular nerve (Berihu and Debeb, 2015). Motor supply to the remaining
plantar flexor muscles, however, is provided by a mixture of the tibial nerve
(innervating the plantaris, tibialis posterior, flexor digitorum longus, and flexor
hallucis longus muscles) and fibular nerve (innervating the fibularis longus and
brevis muscles). The arrangement and activation of muscles crossing the
talocrural joint becomes especially pertinent when considering that contractile
function is assessed using electrically-evoked contractions: currently existing
tools and techniques make simultaneous stimulation of all plantar flexor muscles
both difficult and impractical. Methodological constraints of this technique will be
addressed more thoroughly later in this dissertation.
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STRENGTH, POWER & FATIGABILITY

Muscle function, in the context of this dissertation, encompasses the
following variables: strength, power, fatigability, contractile properties, and neural
drive. These are parameters used in this dissertation to understand
neuromuscular function in people with AT.

Strength
In a laboratory setting, maximal strength is commonly measured using
maximal voluntary contractions (Gandevia, 2001). This technique involves
maximal-effort muscle activation while the muscle is being shortened
(concentric), lengthened (eccentric), or maintained at approximately the same
length (isometric activation). To ensure maximal effort, several factors are
required of the researcher: familiarization to the task; real-time visual feedback of
task performance for the participant; strong, verbal encouragement; ensuring
each effort was perceived as “maximal” by the participant; and incentivizing
maximal effort (Gandevia, 2001). Maximal strength is commonly correlated with
physiological cross-sectional area of a muscle (Hunter et al., 2017). Crosssectional area is a reflection the number of contractile proteins in parallel.
Assuming maximal effort by the participant, it is proportional to maximal force
potential.
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Power & Work
Work is the product of force and displacement. When applied to joints in
the body, it is the product of torque and angular displacement. Power is the rate
of performing work: the product of force and velocity (Blanpied and Neumann,
2017). Angular power, then, is the product of torque and angular velocity. It can
be calculated by multiplying the torque and velocity produced during dynamic
(i.e., concentric or eccentric) maximal voluntary contractions. During isometric
contractions, however, no displacement occurs. Therefore, mechanical work and
power are equal to zero. Work and power are expressed as positive values for
concentric activations, as force and displacement occur in the same direction. In
contrast, force and displacement occur in opposite directions during eccentric
activations. As such, work and power are expressed as negative values.

Fatigability
Performance fatigability refers to an acute decline in an objective measure
of motor performance following an activity (Enoka and Duchateau, 2016). It is
often quantified as either the time elapsed or repetitions completed prior to task
failure (Hunter et al., 2004b). In a laboratory setting, it is commonly defined as an
acute, exercise-induced loss in maximal strength or power (Enoka and
Duchateau, 2008, Hunter, 2018). While both are meant to describe to muscle
function, strength and fatigability are often unrelated. However, when they are
associated, it is often through an inverse relationship, such that stronger muscles
demonstrate worse endurance (i.e., are more fatigable) (Hunter et al., 2004a).
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Resting Twitch Torque: a Measure of Contractile Mechanisms
Force achieved during muscle contraction is dependent upon many
factors, whether at baseline or following fatiguing exercise. They include – but
are not limited to – signal propagation across the neuromuscular junction, motor
unit number and recruitment, excitation-contraction coupling, skeletal muscle
metabolism, and cross-bridge kinetics (Toth et al., 2013, Hepple and Rice, 2016,
Fitts, 1994, Fitts, 2008, Sundberg et al., 2018a). The ability of muscle to contract
independent of the central nervous system can be evaluated using electrical
stimulation of a muscle (or its motor nerve) while the muscle is at rest (RT). The
resultant torque from such stimulation can elucidate possible mechanisms
contributing to altered muscle function. This technique is limited, however, by its
inability to identify which specific mechanisms are contributing to altered function
within the muscle. Instead, “contractile mechanisms” refers to any mechanism
distal to the point where electrical stimulation is applied.

Voluntary Activation: a Measure of Neural Drive
Voluntary activation refers to the ability to drive the muscle using the central
nervous system. It is commonly measured using the Interpolated Twitch
Technique, a technique that involves electrically stimulating a muscle or nerve at
rest and during a maximal voluntary contraction (MVC) (Gandevia, 2001). The
amount of additional torque produced by supramaximal electrical stimulation
during MVCs is known as the superimposed twitch torque (SIT). Electrical
stimulation is then repeated at rest, in a post-activation, potentiated state. The
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amount of torque produced by electrically stimulating the resting muscle is known
as the resting twitch torque (RT). Voluntary activation is the ratio of SIT to RT,
expressed as a percent (Gandevia, 2001): (1-SIT/RT)*100. This technique will be
used to determine neural drive in healthy controls and in people with AT.

PAIN PERCEPTION

One common clinical evaluation of pain intensity is the Numeric Pain Rating
Scale (NPRS). This evaluation tool utilizes an 11-point scale, where 0 is
equivalent to no pain and 10 is equivalent to the worst pain imaginable. Pain can
also be evaluated using algometry, which evaluates pain thresholds in response
to pressure stimuli. Pressure is applied to a particular location and is increased at
a constant rate. The test is complete when the participant indicates that the
sensation has transitioned from being that of pressure to being painful. The
outcome of interest is the corresponding pressure at which the person first
experiences pain.
Pain is often the reason compelling us to seek medical intervention. In one
study, 40% of the patients seeking consultation with a primary care physician
listed pain as their primary complaint (Mäntyselkä et al., 2001). For this reason
alone, it is an important variable to monitor in AT. Its importance is amplified
when considering the inhibitory role of pain on muscle function.
Group III and IV muscle afferents respond to chemical and mechanical
changes in the muscle, including nociception (Martin et al., 2008). Activation of
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these afferents can impact the motor pathway, from motoneurons to the motor
cortex (Martin et al., 2008, Garland and Kaufman, 1995, Hunter, 2018). Thus,
functionally, pain can result in decrements in voluntary activation.

PATHOPHYSIOLOGY OF MIDPORTION ACHILLES TENDINOPATHY

AT is an overuse injury of insidious onset. It results in pain and perceived
stiffness localized within the free tendon that connects the triceps surae muscles
to the calcaneus (van Sterkenburg and van Dijk, 2011, Calder et al., 2010). AT
commonly accompanies a sudden increase or change in activity level (Martin et
al., 2018, Cook et al., 2002). Beyond this, however, the pathophysiology of AT is
poorly understood (Abate et al., 2009, Fredberg and Stengaard-Pedersen, 2008).
As discussed in the context of nomenclature (below), even the roles of
inflammation and degeneration in AT are inconclusive. Consequently, the current
diagnostic and management strategies for people with AT relies heavily upon
clinical presentation (namely, impairments and functional limitations) and less so
on the underlying pathophysiological processes (Scott et al., 2020, Abate et al.,
2009).

Nomenclature & the Roles of Inflammation and Degeneration in Tendon
Pathology
Terminology for Achilles tendon overuse injuries has evolved alongside improved
understanding of the pathophysiology. The evolution has reflected technological
and clinical advances. The chosen terminology is more than a nuance of
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nomenclature; rather, accurate description aids in selecting optimal interventions
and ensuring appropriate understanding of the chronicity and prognosis of the
underlying condition (Andres and Murrell, 2008, Maffulli et al., 1998).
Overuse tendon injuries were originally termed “tendonitis” (Schanz, 1905,
Clancy et al., 1976, Nelen et al., 1989). The assumed pathophysiology was
inflammation of the tendon, which fit within widely-accepted models of tissue
injury and recovery (Ross, 1968, Voleti et al., 2012, Broughton et al., 2006) and
provided an explanation for the presence of pain (Fredberg and StengaardPedersen, 2008). However, as early as the 1980’s, histopathologic evidence
began to emerge that suggested an intriguing theory: despite the presence of
pain, not all tendon overuse disorders involved inflammation (Perugia et al.,
1986, Regan et al., 1992, Kraushaar and Nirschl, 1999, Leadbetter, 1992),
thereby making the “-itis” suffix inaccurate and confusing. These experts
recommended the term “tendinosis”, which was based on evidence of
degeneration within the tendon. The strict definition for tendinosis, however,
required that inflammation did not accompany degenerative changes (Puddu et
al., 1976). Newer evidence began demonstrating that inflammation may indeed
be an important part of the pathophysiology (Cetti et al., 2003, Schubert et al.,
2005). From a clinical perspective, it became evident that degenerative tendons
were not necessarily symptomatic (Maffulli et al., 1998, van Dijk et al., 2011,
Haims et al., 2000, Miniaci et al., 1995, Docking, 2021a, Docking, 2021b), and
that the magnitude of degeneration did not predict symptom severity (Khan et al.,
1997, Cook et al., 2001).
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It is currently recommended that “tendinopathy” be used for clinical
diagnoses and that “tendinosis” and “tendonitis” be reserved only for diagnoses
based on results of histopathologic analyses (Maffulli et al., 1998). It is becoming
increasingly accepted that inflammation and degeneration may both be relevant
fixtures of the disease process (Abate et al., 2009, Fredberg and StengaardPedersen, 2008). However, consensus by tendon experts remains unchanged:
the clinical terminology recommended for describing overuse tendon pathology is
“tendinopathy” (Scott et al., 2020).
One final and important consideration is that of diagnostic specificity.
Pathology of the Achilles tendon can involve more than the midportion of the
tendon: it can include injury of the paratenon; it can be localized to the calcaneal
insertion of the tendon; it can be the result of systemic disease processes,
posterior ankle impingement, or neural irritation; and it can involve partial to
complete tears of the tendon (Fredberg and Stengaard-Pedersen, 2008, Kearney
and Costa, 2010, Martin et al., 2018, Pierre-Jerome et al., 2010).
Pathophysiological processes, clinical presentations, and recommended
interventions for these conditions vary (Kearney and Costa, 2010, Martin et al.,
2018, Rees et al., 2009). Therefore, it is recommended that these conditions be
considered in the differential diagnosis of midportion AT, and not as part of a
larger clinical picture, as these other conditions could confound diagnosis,
prognosis, and intervention in midportion AT (Martin et al., 2018). As such, this
dissertation focuses specifically on midportion AT. Any subsequent reference to
“Achilles tendinopathy” refers only to midportion AT unless clarified otherwise.
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SIGNS, SYMPTOMS, & ONSET IN MIDPORTION ACHILLES TENDINOPATHY

The hallmarks of AT include the following: tendon pain and stiffness; a
stereotypical mechanism of injury; and increased tendon thickness (Cook et al.,
2002). Symptom onset is gradual and insidious, and it commonly follows a
sudden change in activity level. Patients commonly report pain or stiffness first
thing in the morning, upon initial weight-acceptance onto their affected lower
limbs. Pain is localized to the tendon and rarely refers elsewhere. Often pain-free
at rest, the symptoms are typically provoked during active plantar flexion efforts.
Clinical diagnosis of AT is based on a cluster of signs and symptoms, in
addition to possessing the stereotypical symptom onset (Martin et al., 2018). The
“cluster” of tests recommended for clinical diagnosis of AT includes four
components: thickening of the midportion of the tendon; movement of the
thickened region during ankle range of motion (known as the Arc Sign) (Reiman
et al., 2014); reproduction of tendon pain upon palpation; and a reduction in
tendon pain on palpation when retested in ankle dorsiflexion (the Royal London
Hospital Test) (Maffulli et al., 2003). Diagnosis of AT can be aided by ultrasound
and magnetic resonance imaging of the tendon. However, imaging is not a gold
standard for diagnosis in AT (Docking et al., 2015a). In a recent study evaluating
imaging in persons with AT and healthy controls, tendon abnormalities were
found to be more reflective of age, body mass index, and physical activity than of
AT symptoms (Docking, 2021a). Furthermore, degenerative changes in
asymptomatic tendons are common: up to 34% show histopathologic changes,
despite being nonpainful (van Sterkenburg and van Dijk, 2011). Therefore, a
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clinical diagnosis of “tendinopathy” is not equivalent to an imaging-based
diagnosis of “tendinosis”.

Incidence & Prevalence
AT is one of the most common overuse injuries of the lower extremities.
The estimated lifetime prevalence of AT is 30% in sedentary individuals and 50%
in endurance athletes (Joseph and Denegar, 2015). Incidence rates are as high
as 9% of runners each year (Kujala et al., 2005).

Predisposing Factors in Midportion Achilles Tendinopathy
A 2014 systematic review evaluated intrinsic and extrinsic risk factors
contributing to AT (Magnan et al., 2014). The highest incidence of AT was
reported in middle-aged males. However, the authors note that the sex
differences findings may be skewed by differing physical activity rates among
males and females included in those studies. Additional intrinsic variables
identified as risk factors for developing AT include increased body weight,
genetic predisposition, blood supply to the tendon, and systemic disease (such
as rheumatoid arthritis, gout, thyroid and parathyroid disorders, diabetes mellitus,
and lipid storage diseases). Only two extrinsic factors were identified: drugs
(such as fluoroquinolone antibiotics, statins, and injected corticosteroids) and
training parameters. Faulty training parameters include cold weather, poor
footwear, abnormal biomechanics, and excessive training load. Only one study
included in the review experimentally evaluated risk factors related to muscle
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function. That study (Mahieu et al., 2006) identified two intrinsic risk factors for
developing AT: insufficient plantar flexor strength and excessive dorsiflexion
range of motion. However, a more recent systematic review (Hasani et al., 2021)
found limited to conflicting evidence for impaired muscle function in AT when
compared to healthy controls.

Sex Differences in Midportion Achilles Tendinopathy
Many researchers cite sex differences in AT, both in prevalence and in
response to intervention (Joseph and Denegar, 2015, Paavola et al., 2000, Kvist,
1991). Many researchers question the presence of a sex difference in incidence
and prevalence of AT, citing differences in physical activity between males and
females included in those studies (Albers et al., 2016, Hopkins et al., 2016).
Understanding sex differences in plantar flexor muscle function may help explain
possible sex differences in AT. However, evidence of sex differences in plantar
flexor strength and fatigability in healthy individuals is largely lacking and will be
addressed in this dissertation.

Pain & Neurovascular Considerations
It follows from the uncertain pathophysiology of AT that the pain experienced by
people with AT – and how this affects function and treatment – is also poorly
understood (van Sterkenburg and van Dijk, 2011). Among asymptomatic
tendons, as many as 34% are found to have histopathological changes (van
Sterkenburg and van Dijk, 2011). Among persons with AT, the degree of
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degeneration does not correspond to symptom severity, and the presence of
inflammation is not guaranteed (Kannus and Jozsa, 1991, van Dijk et al., 2011,
Cook et al., 2001, Docking et al., 2015a). In the absence of inflammation,
proposed pain mechanisms are largely related to neuro-vasculature (Alfredson et
al., 2003, Ackermann, 2013, Joseph and Denegar, 2015).
Neovascularization refers to a process whereby new vascular networks
form, often as a component of wound healing (Brey and McIntire, 2008). Based
on correlations between pain and neovascularization (Ohberg et al., 2001, Khan
et al., 1999) – including improvements in pain when treating these new vessels
(Alfredson and Ohberg, 2005) – some argue that the angiogenesis must be
contributing to the pain experience. Similarly, neural ingrowth into the tendon
itself has been identified and proposed as a contributing mechanism to pain
(Andersson et al., 2007, Schubert et al., 2005, van Sterkenburg and van Dijk,
2011). However, both the role of neovascularization and neural ingrowth in AT
pathophysiology and their contributions to pain are still under investigation (Rees
et al., 2009, Boesen et al., 2006, Abate et al., 2009, Blackbourn et al., 2012).
Finally, while their role in pain is unclear, a role for angiogenesis seems intuitive:
enhanced blood supply assists in providing the optimal environment for tissue
healing (Abate et al., 2009). This is particularly relevant in tendon, a connective
tissue with limited vascular supply, which likely contributes to chronicity in AT
(van Sterkenburg and van Dijk, 2011, Doral et al., 2010).
Pain in AT has been described both in the context of peripheral and
central sensitization (Plinsinga et al., 2018, Eckenrode et al., 2019, Tompra et al.,
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2016, Skinner et al., 2014). Peripheral sensitization refers to increased sensitivity
of pain receptors to painful and non-painful stimuli, while central sensitization is
increased sensitivity resulting from widespread somatosensory changes
(Graven-Nielsen and Arendt-Nielsen, 2002, Plinsinga et al., 2018). Measuring
sensitivity to mechanical stimuli is one method used to understand changes in
peripheral and central pain sensitivity (Graven-Nielsen and Arendt-Nielsen,
2002). One such method, pressure-pain threshold (PPT) testing, measures the
minimum pressure required to induce pain (Nussbaum and Downes, 1998).
Evaluation of PPTs local to and remote from injured tissue can elucidate
peripheral and central mechanisms, respectively, that are contributing to a painful
experience (Graven-Nielsen and Arendt-Nielsen, 2002, Curatolo et al., 2001).
Algometry is a reliable method for evaluating PPT both within and between
sessions (Potter et al., 2006, Vanderweeën et al., 1996, Nussbaum and Downes,
1998, Frank et al., 2013) and is recommended when evaluating pain in persons
with tendinopathy (Kregel et al., 2013).
Although the underlying pain mechanisms in AT are unclear, it is
nevertheless important to quantify the magnitude of pain experienced by chronic
pain populations and to understand the complex interactions between pain and
movement that result (Merkle et al., 2018, Graven-Nielsen and Arendt-Nielsen,
2002). Pain is often assumed to serve a protective role in musculoskeletal health,
such as inhibition of muscle activation to enable tissue healing. However, it can
also lead to maladaptive changes within the motor system, including persistent
abnormalities in motor control and muscle function, despite resolution of tissue
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injury (Merkle et al., 2020, Hodges and Smeets, 2015). Understanding the
interactions between pain and performance will contribute to improved clinical
management of persons with AT.

STRENGTH & FATIGABILITY IN ACHILLES TENDINOPATHY

AT research has largely focused on histopathology and biomechanical
characteristics of the tendon (Cook et al., 2016). However, the extent of tendon
abnormalities is often unrelated to symptom severity (Martin et al., 2018).
Therefore, while a focus on the tendon is logical (pain is localized within the
tendon), it is likely an incomplete approach. Importantly, tendon injury may result
from many other intrinsic and extrinsic factors (Magnan et al., 2014). Recall that
muscle is the force generator for loads expressed across the tendon. Perhaps,
for this reason, insufficient strength and increased fatigability of the attached
triceps surae muscles are important factors in the pathophysiology of AT.
Interestingly, a 2006 prospective study evaluating military cadets for risk
factors related to Achilles tendon injury found that the most significant predictors
for eventual AT diagnosis were reduced baseline plantar flexor strength and
increased dorsiflexion range of motion (Mahieu et al., 2006). None of the other
variables, including Achilles tendon stiffness, plantar flexion power, activity level,
and anthropometrical characteristics, were significant predictors of subsequent
injury in their study (Mahieu et al., 2006). While causation cannot be attributed in
this type of study design, it is intriguing to consider that baseline plantar flexor
strength – not tendon stiffness – was associated with AT onset. However, an
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important limitation in this study was the diagnostic requirement that dorsiflexion
increased the patients’ perceived pain. This is in direct opposition to the
recommended clinical cluster in AT, which requires reduction in tendon pain
during ankle dorsiflexion (also known as the Royal London Hospital Test)
(Maffulli et al., 2003, Martin et al., 2018).
Since the time of this prospective study, a 2016 Delphi study evaluated risk
factors for developing AT (O'Neill et al., 2016). Based on consensus from tendon
experts around the world, they concluded that muscle strength deficits increase
the risk of developing AT and that plantar flexor strengthening interventions can
help prevent AT onset. However, the premise of muscle strength deficits in AT
was based, in part, on opinion or the assumptions made by review authors,
researchers, and clinicians (O'Neill et al., 2016, Skjong et al., 2012, Murtaugh
and Ihm, 2013). More recently, a systematic review (Hasani et al., 2021) found
conflicting evidence for plantar flexor muscle impairment between people with AT
and healthy controls and limited evidence for between-limb differences in
maximal plantar flexor torque.
The potential relevance of muscle function in AT, however, cannot be
dismissed. The highest quality evidence for treatment in AT advocates the use of
strengthening programs (Martin et al., 2018). However, treatment interventions in
AT are often inadequate, inefficient, or unsuccessful (Paavola et al., 2000,
Paavola et al., 2002, Bohu et al., 2009). Addressing abnormalities in
neuromuscular function has been proposed as an important component to
successful intervention in AT (O'Neill et al., 2015, Debenham et al., 2016, Grigg
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et al., 2013), and strength gains occasionally accompany improvement in AT
symptoms (Malliaras et al., 2013b). However, it is unclear whether this is simply
a byproduct of sufficiently loading the diseased tendon (Bohm et al., 2015,
Hasani et al., 2021). Understanding whether – and which – muscle impairments
must be addressed when treating AT would optimize treatment selection and
improve prognosis.
Insufficient understanding of the underlying plantar flexor muscle function
likely contributes to poor prognosis in AT. Yet, empirical evidence is inconclusive,
as it pertains to the role of strength and fatigability of the plantar flexors in AT.
Furthermore, there is no research that describes either the role of intramuscular
impairment in the plantar flexor muscles or possible inhibition of the nervous
system that innervates the plantar flexors as they contribute to AT. The skeletal
contractile tissue that loads the tendon may be at least partially responsible for
the relative overload of the tendon, whether through altered contractile properties
or differences in activation of the muscle fibers. Understanding the basic
contractile properties and neural drive to the muscle that loads the Achilles
tendon during different muscle activation types and during fatiguing plantar flexor
exercise will inform best strategies for prevention and rehabilitation from AT.

Clinical Evaluation of Plantar Flexor Function
In a clinical setting, plantar flexor muscle function is commonly quantified
using the Single-Leg Heel Raise Test (SLHR) (Hislop et al., 2013). The SLHR is
included as part of manual muscle testing. However, unlike typical manual
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muscle testing, which evaluating muscle strength isometrically, the SLHR is a
dynamic task performed to task failure (Hébert-Losier et al., 2009, Lunsford and
Perry, 1995). As its name implies, the task involves repetitions of heel raises
while standing on one leg. The number of repetitions completed is often
translated into a muscle strength grade (Hislop et al., 2013).
Concerns have been raised regarding the validity of the SLHR as a
measure of muscle strength when based solely on repetitions completed (HarrisLove et al., 2014, Sman et al., 2014, Haber et al., 2004, Möller et al., 2005,
Silbernagel et al., 2006). As a result, many modifications have been
recommended, including: performing the SLHR using specialized devices; using
a weight belt; or including measurements of work or power. Differences in plantar
flexor function are then reported using these new parameters. While these
modifications improve the objectivity of the SLHR, it remains unclear how the
SLHR can isolate itself to plantar flexor function alone.
In AT, changes in plantar flexor function are often reported through the
lens of SLHR performance. This includes reporting evaluating repetitions
completed (Silbernagel et al., 2001, Rabusin et al., 2019, Neeter et al., 2003,
Silbernagel et al., 2007a, Silbernagel et al., 2007b), work performed (Silbernagel
et al., 2001, Silbernagel et al., 2007a, Silbernagel et al., 2007b, Boesen et al.,
2017) or power demonstrated (Silbernagel et al., 2007a, Silbernagel et al.,
2007b) during the SLHR. Therefore, it is important to understand the advantages
and disadvantages of using the SLHR to quantify plantar flexor muscle function,
both at baseline (as in healthy populations) and in AT.
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Clinical Interventions for Chronic Midportion Achilles Tendinopathy
Strengthening of the plantar flexor muscles via eccentric activation –
activation while the muscle is simultaneously being lengthened – is commonly
recommended to increase function and reduce pain with AT (Murtaugh and Ihm,
2013, Martin et al., 2018). However, the underlying mechanism for the
improvements in pain, function, and efficacy over alternative strength training
(often using concentric activations, where the muscle is activated while its length
is shortening, or isometric activations, where the muscle is activated while being
maintained at a static length) has not been established (Skjong et al., 2012).
Despite the possible benefit of eccentric muscle activation, baseline muscle
strength during different activation types (eccentric, concentric, and isometric)
and during repeated activations that induce muscle fatigue – which form the
basis of strength training programs – have not been elucidated in people with AT.
Furthermore, the precise neural and contractile mechanisms that may contribute
to any differences in fatigability between people with AT and controls are not
known.
The frequent successes of eccentric plantar flexor muscle strengthening
suggest an underlying strength deficit during lengthening muscle activations
which is reversed with appropriate training. The magnitude of plantar flexor
muscle strength changes, including the relationship between maximal muscle
strength between concentric and eccentric activation modes and the contractile
and neural mechanisms underlying these changes, have yet to be determined.
Often, studies have focused on the biomechanical aspects of the tendon rather
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than evaluating the intimately related muscular tissue (Chaudhry et al., 2015,
Grigg et al., 2009, Rees et al., 2008). Further, even in the healthy tendon, there
are inconsistencies within the literature regarding the tendon response to
exercise (Svensson et al., 2016). A greater understanding of the baseline
characteristics and response to fatiguing plantar flexor exercise will prove
beneficial when selecting treatment techniques in AT and for prevention efforts.

SPECIFIC AIMS

The overarching aim of this dissertation is to characterize neuromuscular
function of the plantar flexor muscles in people with AT compared with healthy
controls, including during a common clinical test (the Single-Leg Heel Raise).
Neuromuscular function is characterized by measurements of isometric and
dynamic strength, fatigability and the contributing mechanisms. This dissertation
seeks to explain the contributing contractile and neural mechanisms and the
influence of pain on differences in calf muscle strength and function in people
with AT and healthy controls. The hypothesis is that limbs with AT will
demonstrate decreased strength of the plantar flexor muscles due to a reduction
in neural drive, impaired contractile properties of the affected limb, and
heightened pain sensitivity compared with both the contralateral limb and with
healthy controls. The related specific aims, objectives and corresponding
hypotheses are detailed below.
Aim 1: Characterize plantar flexor muscle strength and fatigability,
including evaluation of the neural and contractile mechanisms and pain
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characteristics of the plantar flexors, during a commonly-used clinical
evaluation, the Single-Leg Heel Raise Test, in young, healthy subjects.
Young, healthy control participants will complete the Single-Leg Heel Raise test
(SLHR). Performance in the SLHR will be compared with baseline maximal
isometric strength of the plantar flexor muscles and with the reduction in maximal
isometric strength following the SLHR. Electrical stimulation of the motor nerve
will be used to stimulate the plantar flexor muscles that attach to the Achilles
tendon to quantify 1) contractile properties of the muscle independent of volition,
2) neural drive to the muscle during maximal isometric strength contractions,
both before and after fatiguing exercise. Sex differences in baseline strength and
in response to fatiguing exercise will be evaluated, including any differential
mechanisms contributing to performance fatigability between men and women.
Aim 1 Hypotheses: Performance in the SLHR will not be associated with a
laboratory measure of maximal plantar flexor strength. There will be no sex
differences in plantar flexor muscle fatigability, and the underlying mechanisms
will contribute to similar degrees within both men and women. At baseline,
however, men will demonstrate higher baseline torque levels.
Aim 2: Determine maximal plantar flexor strength during isometric and
dynamic maximal contractions, including evaluation of the neural and
contractile mechanisms and pain characteristics, as they relate to AT.
Maximal isometric, concentric and eccentric strength of the plantar flexor
muscles, baseline pain sensitivity, and the contractile and neural properties of the
plantar flexor muscles will be compared in people with a current diagnosis of AT
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and healthy controls matched for limb dominance. Electrical stimulation of the
muscle is used to stimulate the plantar flexor muscles that attach to the Achilles
tendon and quantify 1) contractile properties of the muscle independent of
volition, and 2) neural drive to the muscle during maximal isometric contractions.
Aim 2 Hypothesis: Tendinopathic limbs will demonstrate decreased strength,
and this will be associated with decreased voluntary activation and heightened
pain sensitivity in the affected limb compared with the contralateral limb and
healthy controls.
Aim 3: Determine plantar flexor muscle fatigability in persons with AT
compared to healthy controls, including the contributing neural and
contractile mechanisms. Fatigability will be assessed using a dynamic clinical
test, the Single-Leg Heel Raise, and during fatiguing isometric exercise.
Fatigability will be compared between groups (i.e., in people with AT compared
with healthy controls) and within groups (i.e., between limbs in people with AT).
Resting twitch torque (contractile properties) of the plantar flexor muscles,
voluntary activation (neural drive) to the muscle during contractions and pain
responses to fatiguing exercise will be compared before and after fatiguing
exercise. Aim 3 Hypotheses: (1) Persons with AT will show greater decrements
in force following a single bout of isometric plantar flexor muscle exercise. (2)
Persons with AT will complete fewer repetitions during the SLHR. (3) Persons
with AT will have greater decrements in voluntary activation and will report
greater magnitudes of pain in the Achilles tendon following fatiguing exercise,
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and these will be associated with greater fatigability following isometric fatiguing
exercise.
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CHAPTER 2 : THE SINGLE-LEG HEEL RAISE TEST
This published article was reproduced with permission from PLOS. The full
citation is listed below.
Sara LK, Gutsch SB, Hunter SK. The single-leg heel raise does not predict
maximal plantar flexion strength in healthy males and females. PLoS One.
(In press) doi: 10.1371/journal.pone.0253276
INTRODUCTION

The single-leg heel raise test (SLHR) is commonly used in clinical practice
as a manual muscle test of plantar flexion strength. It is a dynamic task,
assigning strength grades based on repetitions completed before task failure
(Hislop et al., 2013). This approach differs from the traditional manual muscle
testing approach, which involves evaluation of maximal isometric strength
against resistance provided by an examiner (Hébert-Losier et al., 2009, Lunsford
and Perry, 1995). While the SLHR is widely adopted in the clinic, there are
several limitations for using it as a measure of antigravity plantar flexion strength.
First, the repetitions required for a maximal strength grade vary widely between
sources, and healthy populations vary between completing zero and 120
repetitions (Hébert-Losier et al., 2009, Jan et al., 2005). Second, task
performance in the SLHR cannot be isolated to plantar flexion across the ankle.
To maintain upright posture during the task, the body must appropriately respond
to perturbations in three planes of motion. Lastly, and perhaps most importantly,
the assertion that the SLHR correlates well with maximal isometric strength is not
validated (Harris-Love et al., 2014), nor supported physiologically. In fact, the
number of repetitions completed before task failure is a measure of performance
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fatigability (endurance), not strength (Enoka and Duchateau, 2008, Hunter et al.,
2004b).
Performance fatigability is an acute, activity-induced decline in an
objective measure of motor performance over time (Enoka and Duchateau,
2016). In laboratory and clinical settings, fatigability is often quantified as an
exercise-induced reduction in the maximal force or power of the exercising limb
(Enoka and Duchateau, 2008, Gandevia, 2001, Hunter, 2018). For submaximal
intensity tasks with a constant load -- such as body weight during the SLHR -fatigability can be quantified as the time or number of repetitions completed
before failure (Hunter et al., 2004b). Fatigability and the contributing mechanisms
(e.g. neural and muscular mechanisms) vary between muscle groups, between
tasks (e.g. dynamic vs isometric tasks), and between populations (Avin and Frey
Law, 2011, Hunter, 2018), including between males and females (Hunter,
2016a). The SLHR purports to measure plantar flexion strength during a dynamic
task. However, strength and fatigability are often not associated, possibly
because the metabolic demands are quite different; in fact, in some populations,
these have an inverse relationship, whereby weaker individuals exhibit a greater
task duration (Hunter et al., 2004a). There is no information on 1) the relationship
between maximal strength and the clinical test of SLHR; 2) the magnitude of
fatigability that occurs during the SLHR; and 3) whether there are differences
between males and females, as is often observed for other tasks (Hunter, 2016a,
Senefeld et al., 2018b, Avin et al., 2010).
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Sex differences in fatigability exist across many muscle groups and tasks,
both in terms of the magnitude of fatigability and the neural and muscular
mechanisms contributing to fatigability (Hunter, 2016a). Males, who are often
stronger, are typically more fatigable than females (Hunter, 2016a). This is
especially true during isometric tasks and is more variable with dynamic fatiguing
tasks (Hunter, 2016a, Hunter, 2016b). If sex differences exist in SLHR
performance, the criteria for muscle grades could differ between populations,
such as between males and females. Importantly, knowledge of these will help
guide clinicians when executing and evaluating the SLHR in clinic.
The purpose of this study was to determine: 1) associations between
SLHR repetitions and measures of maximal plantar flexion strength, assessed as
baseline maximal voluntary isometric contraction (MVIC); 2) associations
between SLHR repetitions and the reduction in MVIC following the SLHR; and 3)
whether sex differences exist in performance of the SLHR. We hypothesized
that: 1) the number of SLHR repetitions would be poorly correlated with a
measure of baseline maximal plantar flexion strength; 2) the number of SLHR
repetitions would be associated with a measure of plantar flexor fatigability
(measured as the reduction in maximal plantar flexor strength); and 3) males
would demonstrate greater fatigability than females (measured as SLHR
repetitions and the reduction in MVIC). To understand the contribution of neural
mechanisms to fatigability of the plantar flexor muscles, the reduction in voluntary
activation (central fatigue) was assessed with the interpolated twitch technique
during MVICs before and after the SLHR (Gandevia, 2001, Senefeld et al.,
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2018b). Muscular mechanisms were assessed as the change in contractile
function and represented as the change in electrically-evoked involuntary
contractions of the plantar flexor muscles (Gandevia, 2001).

MATERIALS & METHODS

Participants
Thirty healthy, young adults (15 males and 15 females, 19-30 years)
volunteered to participate in the study. Exclusion criteria included known
cardiovascular disease, neurological disease, and a history of musculoskeletal
injury to the right lower extremity. Informed consent was obtained from all
participants prior to participation in the study. The study protocol was approved
by the Marquette University Institutional Review Board and in compliance with
the Declaration of Helsinki.
All testing took place during one session by the same researcher and was
performed on the right lower extremity. The study involved measures of strength
(MVIC), voluntary activation and contractile properties of the plantar flexor
muscles while seated in a Biodex dynamometer (Biodex System 3 Pro; Biodex
Medical; Shirley, NY) before and after a single-leg heel raise task (SLHR)
performed to failure. The SLHR was performed in the upright standing position
on a custom-made heel raise device placed adjacent to the Biodex dynamometer
(Figure 2.1B). Physical activity data were calculated based on responses to a 12-
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month self-report physical activity questionnaire, the Modifiable Activity
Questionnaire (MAQ) (Kriska, 1997).

Experimental Setup
Each participant was seated in a Biodex dynamometer to quantify forces
during the MVIC and assess voluntary activation and contractile properties of the
right plantar flexor muscles. The right hip and knee were flexed to 90 degrees,
the thigh resting on a padded thigh support, and the foot resting on a foot plate
affixed to the dynamometer (Figure 2.1 A). To minimize extraneous movement
and isolate exercise to the right ankle joint, straps were placed across the waist,
chest, and right thigh. Two straps were used around the ankle and one around
the forefoot to maintain the plantar surface of the foot in contact with the foot
plate. The right ankle was placed in a neutral position, with the foot perpendicular
to the shank.

Baseline Measures
Participants performed MVICs of the plantar flexors with two-minutes rest
between trials. Each participant performed at least two trials, repeating these
until no further torque increases resulted (determined as two MVICs within 5% of
each other).
The right tibial nerve was stimulated using a constant-current, variable
high-voltage stimulator (DS7AH; Digitimer Ltd; Hertforshire, UK) to evoke
contractions to assess contractile properties at rest and during MVICs (voluntary
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activation). Stimulation was applied to the right tibial nerve using a bar electrode
at the medial popliteal space distal to the sciatic nerve bifurcation. Single squarewave pulses of 100µs duration (400 V, 100 Hz) were delivered with a stimulation
intensity initiated at 50mA and gradually increased until a plateau was reached,
such that further increases in stimulation intensity resulted in no additional
increases in evoked torque (Sundberg et al., 2018b, Senefeld et al., 2018b). The
plateau intensity was increased further by 10%. This stimulation intensity was
used during a single pulse stimulation and double pulse of stimulation (at 100Hz)
to enable assessment of contractile properties and voluntary activation,
respectively, of the plantar flexor muscles.
MVICs were repeated with the addition of both a superimposed doublet
stimulation (SIT, superimposed twitch) followed by a resting (potentiated) doublet
stimulation (RT, resting twitch) of the tibial nerve ~2 seconds after the MVIC
(Figure 2.1 C). Doublet stimulations were used for the SIT, as this has been
shown to be more sensitive (Rozand et al., 2020, Oskouei et al., 2003). The
forces during the SIT and RT were used in the analysis of voluntary activation and
resting twitch torque (see Data Analysis). Each participant performed four MVICs
with two minutes of rest between each trial.
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Figure 2.1. Experimental setup, study protocol, and raw data.A: Experimental
setup of a participant in the Biodex System3 Pro dynamometer used for baseline
and post-SLHR task measurements. Participants were given visual feedback on a
monitor. Surface electromyography (EMG) was recorded for the medial and lateral
gastrocnemius, soleus, and anterior tibialis muscles. Electrical stimulation was
positioned over the tibial nerve. B: Experimental setup for the SLHR task.
Participants stood on a custom-made heel raise device (see inset). Surface EMG
was similarly recorded for the duration of the SLHR task. C: Representative torque
data from a female participant, before and after the SLHR task. Measurements
included: maximal voluntary isometric contraction (MVIC), superimposed twitch
(SIT), and resting twitch (RT). The MVIC decreased and SIT increased following
the SLHR task, leading to reduced voluntary activation. D: Root-mean-squared
(RMS) EMG data recorded during the SLHR task. The representative data is from
the lateral gastrocnemius of the female participant from C and shows an increase
in EMG amplitude.

Single-leg heel raise task
The SLHR involved repeated heel raises of the right leg while in upright
standing. The SLHR task was performed using a custom-made heel raise device
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(Figure 2.1 B) that included a horizontal plate affixed above a standing surface by
an upright support bar. The horizontal plate served as a visual and tactile target
during the SLHR and was adjustable in both the vertical and anteroposterior
dimensions. The position of the horizontal plate was selected as the maximum
height achieved during a single-leg heel raise for each subject, adjusted to the
dorsal ankle crease at end-range during a single-leg heel raise.
Participants were familiarized and provided instruction about on
performance of the SLHR prior to the baseline measures. This included the
importance of contacting the horizontal target plate at each repetition and to
demonstrate slow, controlled lowering during the eccentric phase of the task.
Instability as a cofounding variable was minimized by allowing use of light
fingertip support in the horizontal plane.
The SLHR was standardized to a pace of one heel raise every three
seconds. This was achieved using a 60 beats-per-minute audible metronome
and verbal cueing of “up, down, rest” to signify three-second epochs wherein
participants took one second each to raise onto their toes, lower down, then rest.
Verbal encouragement was provided and the SLHR was performed until task
failure, defined as two consecutive missed contacts with the horizontal target
plate. Participants were blinded to the failure criteria.

Post SLHR Task Measurements
Upon task failure, the participant was returned immediately to the Biodex
for post-task measurements of MVIC with a SIT followed by resting twitches two
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seconds post MVIC. These measurements began at 45 ± 8 sec and were
repeated at 1, 3, 5, 7, 9, and 11 mins post-SLHR.

Electromyography (EMG)
EMG activity of the medial gastrocnemius, lateral gastrocnemius, soleus,
and tibialis anterior was recorded using bipolar EMG electrodes (Ag–AgCl, 8-mm
diameter; 20 mm inter-electrode distance; Natus Medical Inc) located over the
muscle bellies in accordance with recommendations by the SENIAM project
(Hermens et al., 2000). In brief, electrodes were placed midway between the
anatomical origin and myotendinous junction of each muscle, in alignment with
the fiber direction of the respective muscle. Data were amplified (4000 Hz;
Coulbourn Instruments, Allentown, PA), digitized (Power1401, Cambridge
Electronic Design Limited, Cambridge, UK) and stored online using Spike2
software (Cambridge Electronic Design Limited, Cambridge, UK).

Data and Statistical Analyses
Thirty people volunteered to participate in this study. The data from one
female and one male were removed because their MVIC torque and voluntary
activation values were more than 3 standard deviations below the group means.
Thus, 14 females (19-30 yrs, 21.1±2.9 yrs) and 14 males (19-26 yrs, 21.5±1.8
yrs) are included in the subsequent data and statistical analyses.
For all analyses of strength, contractile properties, and voluntary
activation, “baseline” refers to the average of values that occurred during the two
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baseline MVICs that yielded the greatest torque amplitudes. “Post-task” refers to
the first MVIC following the SLHR.
MVIC was measured as the average of a 0.5-second window surrounding
the maximum torque. Voluntary activation was calculated as the ratio of the
superimposed to the resting doublet twitch (Gandevia, 2001): (1-SIT/RT)*100.
The resting twitch refers to the torque amplitude of the electrically-evoked
potentiated resting doublet stimulation that occurred immediately after an MVIC.
Muscle activity was quantified as the root-mean-square (RMS) value of
the electromyography (EMG) signals for each the medial and lateral
gastrocnemius, soleus, and tibialis anterior. Maximal baseline EMG was
measured over the same 0.5-second interval as the MVIC, and this was used to
normalize EMG data from the SLHR. For the SLHR, EMG data was quantified as
the RMS value over a 0.5-second interval surrounding the maximal EMG activity
recorded during each SLHR repetition.
Independent samples t-tests were used to compare physical
characteristics, physical activity levels, number of SLHR repetitions completed,
and baseline measures of strength, muscle properties and voluntary activation
between males and females. Repeated-measures ANOVAs were used to
evaluate changes in MVIC torque, electrically-evoked resting twitch amplitude,
and voluntary activation from baseline to immediately post-SLHR, using time as
the within-subjects factor and sex as the between-subject factor. Similarly,
repeated-measures ANOVAs were used to evaluate changes in EMG activity
from start to end of the SLHR task, using time as the within-subjects factor and
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sex as the between-subjects factor. For all ANOVAs, Greenhouse-Geisser
corrections were used whenever the assumption of sphericity was violated.
Mediation analyses were utilized to evaluate the impact of body weight on the
relationships between sex and the outcome variables (Field-Fote, 2019).
Pearson correlation was used to evaluate associations between SLHR
repetitions, baseline dependent variables, and changes in dependent variables
from pre- to post-task. Normality was assumed for all variables based on
histograms and Q-Q plots. Significance was determined a priori at p < 0.05. Data
are reported as mean ± standard deviation (SD) in the text and displayed as
mean ± standard error of the mean (SEM) in the figures. All analyses were
performed in IBM Statistical Package for Social Sciences (SPSS, V26).

RESULTS

Males and females were similar in both BMI and in self-reported physical
activity levels, while males had more mass and were taller (see Table 2.1).
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Table 2.1. Participant demographics & baseline characteristics.
Variable

Units

Males

Females

p-value

n
14
14
Age
yrs
21.5±1.8
21.1±2.9
0.58
*Height
m
1.81±0.08
1.66±0.07
<0.001
*Weight
kg
79.4±10.3
64.0±10.8
0.001
BMI
kg·m ̄ ²
24.3±2.3
23.2±3.1
0.27
Physical
met·hr·wk ̄ ¹ 66.6±26.6
59.5±35.0
0.55
Activity
MVIC
Nm
148.8±36.3 128.1±34.1 0.20
RT
Nm
32.6±9.9
25.7±8.5
0.06
VA
%
91.5±8.2
90.9±10.2
0.87
SLHR
reps
32.6±6.9
39.4±14.8
0.14
* p<0.05; ** p<0.01.
BMI, body mass index, MVIC, maximal voluntary isometric contraction; RT,
potentiated resting twitch amplitude; VA, voluntary activation; SLHR, single leg
heel raise.

SLHR and MVIC
There was no difference in the number of SLHR repetitions performed to
task failure by males and females (p=0.14, Figure 2.2). At baseline, there was no
sex differences in MVIC torque (p=0.198, Figure 2.3, “baseline”). The SLHR task
resulted in 20.5% reductions in MVIC torque from baseline for all participants
(time effect, p<0.001). However, there was no sex difference in the reduction of
MVIC (sex effect, p=0.14, males 18.6% and females 22.7%; Figure 2.3) and no
interaction of sex and time (p=0.865). Normalizing MVIC torque to body weight
did not change these results: baseline torque remained similar between groups
(p=0.479); MVIC torque following the SLHR was not different between groups
(p=0.808); and post-task reduction in MVIC was similar between males and
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females (p=0.532). Furthermore, body weight did not mediate the relationship
between sex and repetitions completed during the SLHR (p=0.206).

Figure 2.2. Box-and-whisker plot of single-leg heel raise (SLHR) repetitions
performed by males and females. The middle line represents the median
values, while the “x” represents the mean values. The left-hand box shows the
pooled results for males and females. There were no sex differences in number
of SLHR repetitions completed at time of task failure (p=0.137).

41

Figure 2.3. MVIC torque before and after the SLHR in males and females.
Torque was reduced following SLHR task for both males (dark gray, 18.6%
reduction from baseline) and females (light gray, 22.7% reduction from
baseline). ** p<0.01.

EMG
RMS EMG (% MVIC) amplitude of the triceps surae did not change from
the start to the end of the SLHR task for males (MG: 17.3% decrease, p=0.351;
LG: 12.2% increase, p=0.081; SOL: 1.9% decrease, p=0.683), but females had
significant increases in all three muscles (sex and time interaction for combined
triceps surae muscles, p=0.029). The females demonstrated increases in the MG
(32.0% increase, p=0.026), LG (52.3%, p=0.011) and SOL (26.4%, p=0.030)
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(Figure 2.4). Bodyweight did not mediate the sex-differences in EMG for any of
the triceps surae muscles (MG, p=0.176; LG, p=0.375; SOL, p=0.070).

Figure 2.4. Change in RMS EMG amplitude for each the soleus, medial and
lateral gastrocnemius, and tibialis anterior muscles from the start to end of
the SLHR task, as a percent of baseline MVIC. EMG for all three plantar flexor
muscles increased in females (striped bars). In males (solid bars), medial
gastrocnemius EMG decreased, while lateral gastrocnemius and soleus EMG
remained unchanged. Tibialis anterior EMG remained unchanged in both males
and females. *, interaction between sex and time, p<0.05.

Voluntary Activation and Twitch Amplitude
There were no sex differences in baseline voluntary activation (VA,
p=0.866) or post-task reduction in VA (p=0.856). There was a significant main
effect of time: the SLHR resulted in reduced VA for all participants (9.8%
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decrease from baseline, p=0.012; Figure 2.5). There were similarly no sex
differences in either baseline resting twitch amplitudes (RT, p=0.057) or post-task

Figure 2.5 Voluntary activation (A) and resting twitch amplitude (B) before and
after the SLHR task in males and females pooled. Voluntary activation decreased
(p=0.01) and resting twitch amplitude increased (p<0.001) following the SLHR task for
males and females (there were no sex differences in response to the SLHR). * p<0.05;
** p<0.01.

change in RT (p=0.357, Figure 2.5). There was a significant main effect of time:
RT increased from pre- to post-task for all participants (17.6% increase from
baseline, p<0.001, Figure 2.5).

Associations
The number of SLHR repetitions performed was not correlated with either
the baseline MVIC (r=-0.005, p=0.979) or the percent reduction in MVIC following
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the SLHR (r=-0.234, p=0.23). The percent reduction in MVIC was positively
associated with the reduction in VA (r = 0.841, p<0.001): those who had the
greatest reductions in MVIC also had the largest reductions in VA. However, the
SLHR was not associated with either baseline VA (r=0.354, p=0.064), reduction
in VA (r=-0.085, p=0.669), baseline RT (r=0.054, p=0.786), or the change in RT
(r=-0.104, p=0.597). Baseline MVIC was not predictive of change in MVIC
(r=0.122, p=0.537): those with greater MVIC torque did not necessarily have
greater (or lesser) reductions in MVIC torque following the SLHR.

DISCUSSION

The novel findings of this study were: (1) the SLHR (number of repetitions
completed at task failure) was not associated with the maximal isometric plantar
flexion strength (MVIC) nor the relative reduction in maximal strength after the
SLHR (fatigability of the MVIC), and (2) there were no sex differences in either
SLHR repetitions completed, MVIC and fatigability of the MVIC, or associations
between these variables. Additionally, our results implicate reductions in
voluntary activation (i.e., neural drive) as a primary mechanism for fatigability of
the MVIC after SLHR in both males and females. Collectively, our results suggest
that the SLHR is not a valid measure of strength but a specific measure of
dynamic-contraction lower limb fatigability that is similar in males and females.
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Fatigability and StrengthThe number of dynamic SLHR repetitions were not
correlated with maximal isometric plantar flexion strength. From a physiological
standpoint, this is expected; strength, represented in this study by brief maximal
isometric voluntary efforts, is typically correlated most strongly with physiological
cross-sectional area, which is indicative of the number of sarcomeres in parallel
in a muscle fiber and muscle (Hunter et al., 2017). Strength is often not predicted
by the ability to maintain a task for a period of time because the physiological
mechanisms involved in continued task performance are quite different from
those involved in generating maximal force for a brief time (Hunter et al., 2004b).
Specifically, failure to maintain the requirements of task over a period of time (in
this case, ~100 seconds) involves the ability of the muscle to meet the metabolic
demands based on the task requirements. During dynamic fatiguing contractions,
fiber velocity slows and maximal force development declines due to increased
metabolites within the muscle (e.g. inorganic phosphate, hydrogen ions), thereby
resulting in fatigability (Sundberg et al., 2019, Kent-Braun et al., 2012).
Furthermore, afferent feedback (group III and IV) due to increased metabolite
accumulations can inhibit motor neurons in the spinal cord and reduce voluntary
drive (Gandevia, 2001, Taylor et al., 2016). Thus, the physiological mechanisms
most relevant to the SLHR are the ability of the muscle to meet the metabolic
demands of the fatiguing task and the ability to maintain neural drive to the
muscle, not the physiological cross-sectional area of the muscle.
In the clinical setting, the SLHR is thought to measure plantar flexion
strength, as purported in manual muscle testing procedures (Hislop et al., 2013).
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However, combined with the absence of physiological basis, the lack of
association between the SLHR and maximal plantar flexion strength in young,
healthy participants calls into question the construct validity of the SLHR.
Importantly, our finding agrees with a prior study evaluating 43 adults with
myositis (64.9 years old), where SLHR repetitions were not correlated with
plantar flexion MVIC (Harris-Love et al., 2014). Concerns with the SLHR have
arisen previously, including: lack of uniform testing parameters (Hébert-Losier et
al., 2009, Sman et al., 2014); and limited sensitivity (specifically, an inability to
differentiate outcomes between treatment groups) (Silbernagel et al., 2010).
Therefore, whether for healthy or clinical populations, the SLHR is likely an
invalid measure of maximal plantar flexion strength.
The plantar flexors experienced reductions in MVIC following the SLHR.
However, these reductions in force were not associated with performance in the
SLHR. In single-joint tasks performed to failure, maximal strength or power is
expected to decrease following task failure (Kent-Braun et al., 2012). This lack of
association between the SLHR and reduction in MVIC indicates that fatigability of
the plantar flexors is task-dependent (Hunter, 2018), as seen in other lower limb
muscle groups. For example, in young, healthy adults, the fatigability of the knee
extensor muscles and involved mechanisms differed for an isometric fatiguing
contraction compared with a dynamic knee extensor tasks (Senefeld et al.,
2018b), because the specific demands of the task dictate the amount of fatigue
and the mechanisms. A decrease in MVIC (isometric) after the SLHR may reflect
a reduction in the number of active cross-bridges (Fitts, 2016, Kent-Braun et al.,
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2012) and, as we showed, a reduction in neural drive. In contrast, a slowing of
velocity during the dynamic contraction fatigue of a SLHR likely reflects the limits
of crossbridge speed and reduction in maximal shortening velocity of the fiber
(Jones, 2010).
Importantly, the SLHR may not be limited to the ankle plantar flexor
muscles. Apart from fingertip support for balance, there are no methods used to
stabilize the body or surrounding joints during the SLHR. Thus, it is probable that
muscles external to the plantar flexors – including foot intrinsic and extrinsic
musculature (DiLiberto and Nawoczenski, 2020, Hutchison and Houck, 2018),
knee extensors, frontal plane hip stabilizers, and core musculature – are
additionally responsible for success (and ultimately failure) in the SLHR. The
SLHR may, therefore, be best interpreted as a functional, dynamic task
evaluating fatigability of the entire lower extremity.

Mechanisms
Our study evaluated measures representing neural and contractile
mechanisms that may contribute to the reduction in MVIC strength of the plantar
flexor muscles after the SLHR and variability in performance of the SLHR.
Voluntary activation – assessed during the MVIC with electrically-evoked
contractions – was reduced following the SLHR and was correlated with the
reduction in MVIC torque, suggesting that decreased neural drive contributed to
fatigability of the MVICs. Conversely, changes in resting twitch amplitude were
not related to the reduction in MVIC, suggesting that contractile mechanisms
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within the plantar flexor muscle group were not responsible for the loss in
maximal plantar flexion force following the SLHR. This is atypical for dynamic
tasks that are constrained to a single limb; typically, changes in maximal strength
following dynamic fatiguing exercise are explained by contractile mechanisms, as
in the knee extensor muscles (Senefeld et al., 2018b). In the case of the SLHR,
this difference may highlight the whole-limb nature of this task. Without
constraining neighboring joints and providing robust balance assistance, several
other muscles must be innervated to enable task continuation. As a result, the
burden on the central nervous system may be greater. Thus, while the SLHR fails
to predict either maximal plantar flexion strength or the magnitude of the
reduction in MVIC, perhaps it is best interpreted as an assessment of whole
lower limb dynamic fatigability.
There were no sex differences in SLHR repetitions completed before task
failure, nor were there differences in maximal strength or fatigability. The lack of
sex differences in strength was surprising given that, on average, men are
stronger than women -- although more so for upper limb muscles (Hunter, 2014).
There were additionally no sex differences in the mechanisms driving fatigability
in the SLHR, including the reduction in voluntary activation, which was similar in
males and females. Neural mechanisms (i.e., voluntary activation) were similarly
associated with fatigability in males and females, while contractile mechanisms
(i.e., resting twitch amplitude) bore no relationship to fatigability in either males or
females.
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Sex differences were observed only in muscle activation levels (EMG
amplitudes) during the SLHR. While males had no increase in EMG amplitudes,
females had significant increases for each the soleus, medial and lateral
gastrocnemius muscles. Typically, repeated submaximal contractions result in
progressive increases in EMG (Enoka and Duchateau, 2008), representative of
further recruitment of motor units as muscle fibers become progressively fatigued
(Bigland-Ritchie et al., 1986). This was evident in the females, but it was not
observed in the males, suggesting that, at least for females, the SLHR was a
submaximal, fatiguing task. The relatively stable soleus and lateral
gastrocnemius EMG amplitudes and the reduction in medial gastrocnemius EMG
amplitude seen in male participants could indicate that the SLHR was a maximal
task for their plantar flexors. However, when combined with the knowledge that
their voluntary activation and MVIC torque both reduced – and to a similar
magnitude as female participants – there is one explanation that seems more
plausible: although the rate of fatigue of the dynamic contractions was similar for
the males and females, they fatigued for different reasons. The EMG data
indicate that males and females utilized different strategies and recruitment of
muscles during the SLHR.
SLHR performance is correlated with many measures of functional
relevance: joint stability, proprioception and balance (Park et al., 2019, Fujiwara
et al., 2011); gait speed and use of an assistive device (Davenport et al., 2014,
Brincks and Nielsen, 2012, Jung et al., 2020). This makes understanding the
fatigability of the plantar flexors and surrounding, supporting musculature during
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the SLHR even more critical. For instance, strengthening of intrinsic foot
musculature alone improved heel raise height and repetitions completed in
persons with flat feet (Hutchison and Houck, 2018). This finding supports our
conclusion that SLHR performance depends upon more than just plantar flexor
function, and it suggests that neuromuscular mechanisms should be investigated
as they relate to fatigability of intrinsic foot muscles. To date, however, the
degree to which intrinsic foot muscles contribute to SLHR performance has not
been investigated, nor have the contributing roles of other muscles acting at the
foot, knee, or hip joints.
There were no sex differences in SLHR repetitions completed in this
study, even when accounting for differences in body weight. Total work
performed, however, may have differed between males and females as a
function of ankle range of motion (Lunsford and Perry, 1995). Furthermore,
differences in muscle function proximal and distal to the talocrural joint may
impact task performance between males and females. The role of stabilizing
muscles in the SLHR, including the neuromuscular mechanisms of these
muscles that contribute to task failure, would assist in identifying whether further
sex differences in SLHR task performance exist and whether these need to be
assessed and addressed during clinical evaluation.

Limitations
Maximal isometric voluntary contractions were used to assess fatigability
after the SLHR, despite the dynamic nature of the task. This selection was
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intentional because: (1) manual muscle testing (MMT) is traditionally performed
as an evaluation of maximal isometric strength; and (2) assessment of voluntary
activation during maximal dynamic contractions in this setting is not yet a reliable
technique. Furthermore, there was ~45 seconds of delay in measuring post-task
maximal strength and contractile properties assessed in the dynamometer. Any
pre- to post-task differences, therefore, reflect the time of measurement and were
not precisely immediately post-task. Finally, lack of a familiarization session
could have impacted MVIC torque (Gandevia, 2001). However, it is unlikely that
the groups would have been differentially impacted by the lack of a familiarization
session. Furthermore, young to middle-aged adults do not exhibit sex differences
in activation (Hunter et al., 2006, Sundberg et al., 2018b) and typically require
minimal practice to achieve optimal activation in a session with no prior
familiarization (Hunter et al., 2008).
Testing in the isokinetic dynamometer (Biodex) utilized a flexed-knee
position, while the SLHR utilizes a straight-knee position. This could affect
interpretations of relative muscle contributions in the SLHR when compared to
MVICs. However, no such comparisons were made between tasks. Importantly,
while the change in knee position may result in altered PF torque, this would not
impact the relationship between the SLHR and MVIC torque: the approximate
85% reduction in PF torque that occurs from 0 degrees to 90 degrees knee
flexion (Landin et al., 2015) would simply be as though a constant multiplier were
added to the equation evaluating correlation between SLHR reps and MVIC
torque, which would not impact the detection of a relationship between these
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variables. Finally, neither sex, BMI category, nor physical activity level impact the
relationship between ankle angle and peak PF muscle activity (Hébert-Losier et
al., 2011). Thus, the choice of testing position in the Biodex is unlikely to have
impacted the between-group findings in this study.

Conclusions
The SLHR is a poor predictor of maximal plantar flexor strength in young,
healthy males and females. As a test of repetitions to failure, the SLHR is wellsuited to evaluate performance fatigability. However, as a task whose
performance is dependent upon several factors - including coordination and
stabilization of proximal and distal muscles and joints - the SLHR more likely
evaluates dynamic fatigability of the lower extremity. Additionally, there were no
sex differences in the number of SLHR repetitions, nor were there sex
differences in maximal baseline plantar flexor strength or plantar flexor
fatigability. Based on differences in muscle activation patterns, males and
females likely utilize different strategies to succeed in the SLHR.

Clinical Relevance
The results of this study reveal a critical limitation in current interpretation of the
SLHR: the lack of association between SLHR repetitions and MVIC diminishes
the validity of using the SLHR as a clinic-based evaluation of plantar flexor
strength. Furthermore, the lack of relationship between SLHR repetitions and
reduction in plantar flexion MVIC suggests that the cause of task failure of the
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SLHR may not be specific to the plantar flexor muscles. Instead, this task may be
best interpreted as a task of dynamic lower extremity fatigability rather than
strength or fatigability specific to the primary plantar flexor muscles involved in
the task. Modifications have previously been suggested to improve the
psychometric properties of the SLHR, including construction of various
specialized devices, addition of linear encoders, utilization of a metronome, and
addition of a weight belt (Haber et al., 2004, Möller et al., 2005, Sman et al.,
2014, Silbernagel et al., 2006). However, the same limitations exist for these
modified protocols: number of repetitions to failure cannot predict plantar flexor
strength, and the SLHR task is not specific to the plantar flexor muscles. Thus, to
evaluate maximal plantar flexor strength in clinic, new clinical measures need to
be developed.
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CHAPTER 3 : PLANTAR FLEXOR STRENGTH IN ACHILLES
TENDINOPATHY
INTRODUCTION

Midportion Achilles tendinopathy (AT) is an overuse injury commonly
attributed to deficient plantar flexor muscle function (Mahieu et al., 2006, O'Neill
et al., 2016). The premise of weak or fatigable plantar flexor muscles in people
with AT is largely based on two factors: (1) insidious onset commonly
accompanies a sudden increase or change in activity level (Martin et al., 2018,
Cook et al., 2002); and (2) strength gains often – but not always (Silbernagel et
al., 2007a, Silbernagel et al., 2001) – accompany improvements in symptoms
and function following rehabilitation (Malliaras et al., 2013a, Alfredson et al.,
1998). However, the empirical evidence supporting impaired neuromuscular
function is sparce and largely inconclusive (Martin et al., 2018, Hasani et al.,
2021).
Maximal voluntary contractions (MVCs) are commonly used to quantify
maximal force-generating capacity of limb muscles (Gandevia, 2001). These
involve maximal-effort muscle activation with a fixed joint position (isometric
MVCs) or changing joint position (concentric and eccentric MVCs). These
voluntary contractions are the result of neural drive to the muscle and the forcegenerating capacity of the muscle (i.e., contractility). Thus, weakness associated
with impaired function, such as may occur in people with AT, could be due to
lower neural drive, muscle atrophy, or an inability of the available muscle to
contract. Understanding the contribution of neural drive and muscular contractility
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to alterations in neuromuscular function, particularly weakness, may inform
treatment selections (Russell et al., 2012, Ochala, 2010). Whether any muscle
weakness assciated with AT is due to impared neural drive or low muscle
contractilty is not known.
Muscle contractility can be evaluated using electrical stimulation of a
resting muscle (Senefeld et al., 2018a). The amount of torque generated from
electrically stimulating a resting muscle (known as resting twitch, RT) provides
insight into the muscle’s ability to contract and its contractile behavior
independent of activation of the nervous system (Heyters et al., 1994, Allen et al.,
1995, Booth and Thomason, 1991). Neural drive, or voluntary activation, refers to
the ability of the central nervous system to activate a muscle. It can be quantified
using the Interpolated Twitch Technique (Gandevia, 2001, Shield and Zhou,
2004). This technique involves electrically stimulating a muscle during a maximal
effort contraction (i.e., an MVC) and then at rest, immediately following the MVC,
during its potentiated state. Voluntary activation is calculated as the ratio of the
torque produced in response to the stimulation during the MVIC (known as a
superimposed twitch, SIT) to the torque produced in the potentiated, resting state
twitch (RT) (Gandevia, 2001): Voluntary Activation (VA) = 100*(1-SIT/RT). Thus,
this technique evaluates the magnitude of additional torque that could be
generated during a maximal-effort contraction when the muscle, motor nerve or
motor cortex are stimulated.
There are other factors that potentially confound muscle function and the
ability to activate optimally during tasks that require maximal strength. Pain for
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example, can influence effort and activation in clinical populations (Briani et al.,
2018, Barker et al., 2004, Merkle et al., 2020, Hodges and Smeets, 2015) and
potentially could contribute to altered activation of the plantar flexor muscles in
people with AT. Activation of group III and IV motor afferent nerves, for example,
can result in inhibition of motoneurons and reduce voluntary activation (Hunter,
2018, Salomoni et al., 2016). Such somatosensory feedback is likely imperative
to protect exercising muscle (Amann et al., 2009, Blain et al., 2016). However, in
chronic pain populations, such inhibition could result in muscle atrophy (Barker et
al., 2004) and persistent abnormalities in neuromuscular function (Briani et al.,
2018, Bennell et al., 2008).
No study has yet evaluated either the neural drive or contractile function of
the plantar flexor muscles or their contribution to potential deficits in strength in
people with AT. To understand neural drive and contractile function of the plantar
flexor muscle we used the interpolated twitch technique and electrically evoked
twitch contractions, respectively. We also assessed the role of pain in influencing
neural drive and contractile function in AT, as this is poorly understood. Thus, the
purpose of this study was to determine the following in persons with AT: 1)
maximal plantar flexion strength and power during isometric and dynamic
contractions; 2) neural drive during maximal effort contractions and contractile
function based on electrically-evoked contractions at rest; and 3) whether pain,
neural drive, and contractile mechanisms contribute to differences in maximal
strength in people with AT.
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MATERIALS & METHODS

Participants
Fourteen participants with tendinopathy (10 males, 4 females; 18-49 yrs)
and 14 controls (7 males, 7 females; 18-32 yrs) volunteered to participate in the
study. Inclusion criteria included the following: gradual, insidious onset of pain
and/or stiffness at the midportion of the Achilles tendon, which had become
chronic (i.e., persisted for at least 3 months (Scott et al., 2011); and healthy
controls without history of either pain or stiffness in the Achilles tendon region.
AT diagnosis was a clinical diagnosis based on the following: gradual, insidious
onset of symptoms; pain and/or stiffness localized to the midportion of the
Achilles tendon; pain with palpation of the midportion of the tendon; a positive
Arc Sign; and a positive Royal London Hospital Test (Martin et al., 2018).
Exclusion criteria included diabetes (Baskerville et al., 2018), thyroid disorders
(Oliva et al., 2013), cardiovascular disease, neurological disease, known
contraindications to exercise, and any acute injury, bursitis, insertional
tendinopathy, or osteoarthritis in either lower extremity. Informed consent was
obtained from all participants prior to participation in the study. The study
protocol was approved by the Marquette University Institutional Review Board
and in compliance with the Declaration of Helsinki.
All testing took place during two sessions and was led by the same
researcher. The first session included completion of clinical measurements and
self-report outcome measures (including the Tampa Scale of Kinesiophobia
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(TSK) (French et al., 2007); the Foot and Ankle Ability Measure (FAAM),
including both the sport and activities of daily living (ADL) subscales (Martin et
al., 2005); and the Victoria Institute of Sport Assessment-Achilles Questionnaire
(VISA-A) (Robinson et al., 2001). Familiarization to the following was provided
during the first session: the Biodex, electrical stimulation protocol (for voluntary
activation and contractile properties) and PPT. The second session involved:
evaluation of isometric MVCs with electrical stimulation (for neural and muscular
properties); concentric and eccentric MVCs; PPT; and body composition (using
Dual X-Ray Absorptiometry). Physical activity data were calculated based on
responses to a 12-month self-report physical activity questionnaire, the
Modifiable Activity Questionnaire (MAQ) (Kriska, 1997).
All testing was completed for both lower extremities. The order of limbs
was randomized every session. Within a given session, testing was completed
on one leg before performing identical testing of the contralateral limb (during the
same session). The study involved measures of maximal strength (both isometric
and dynamic), pressure-pain threshold (PPT), voluntary activation and contractile
properties of the plantar flexor muscles while seated in a Biodex dynamometer
(Biodex System 3 Pro; Biodex Medical; Shirley, NY).

Experimental Setup
Each participant was seated in a Biodex System 3 Pro dynamometer. The
test position involved a straight knee (0 degrees flexion) with a trunk angle of 55
degrees. The trunk recline was utilized to minimize any hamstring discomfort and
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sciatic nerve tension during testing. The thigh rested on a padded thigh support,
and the foot rested on a foot plate affixed to the dynamometer (Figure 3.1). To
minimize extraneous movement and isolate exercise to the ankle joint, straps
were placed across the waist, chest, and thigh. Two straps were used around the
ankle and one around the forefoot to maintain the plantar surface of the foot in
contact with the foot plate during strength testing. For PPT measurements, the
ankle straps were removed to access the Achilles tendon, and the ankle was
placed in a neutral position, with the foot perpendicular to the shank.

Baseline Measures
Participants performed maximal voluntary isometric contractions (isometric
MVCs) of the plantar flexors with two-minutes rest between trials. Each
participant performed at least two baseline isometric MVC trials, repeating these
until there was no further increase in torque by >5%.
The ipsilateral tibial nerve was stimulated with a bar electrode and a
constant-current, variable high-voltage stimulator (DS7AH; Digitimer Ltd;
Hertforshire, UK) to evoke contractions to assess contractile properties at rest
and during isometric MVCs to assess voluntary activation. Stimulation was
applied to the ipsilateral tibial nerve using a bar electrode at the medial popliteal
space distal to the sciatic nerve bifurcation. Single square-wave pulses (400 V,
100µs duration) were delivered with a stimulation intensity initiated at 50mA and
gradually increased until a plateau was reached, such that further increases in
stimulation intensity resulted in no additional increases in evoked torque
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(Senefeld et al., 2018b, Sundberg et al., 2018b). The plateau intensity was
increased further by 10% to ensure supramaximal stimulation during assessment
of contractile properties and voluntary activation of the plantar flexor muscles.

Figure 3.1. Experimental setup of a participant in the Biodex System3 Pro
dynamometer used for plantar flexor strength measurements. Participants
were given visual feedback on a monitor. Surface electromyography (EMG) was
recorded for the medial and lateral gastrocnemius, soleus, and anterior tibialis
muscles. Electrical stimulation was positioned over the tibial nerve.
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A)

B)

Figure 3.2. PPT measurement locations. A, Pressure-pain thresholds were
measured twice at each of three locations: Achilles tendon, medial
gastrocnemius, and upper trapezius (marked with an “x”). B, Tendon
measurements were completed using the pinch handle attachment of the
Somedic Algometer.

Pressure-Pain Thresholds
Pressure-pain thresholds (PPTs) were measured using an algometer
(Somedic SenseLab AB, Sweden) with a 1cm2 probe tip at an application rate of
30 kPa/s while the participant was seated in the dynamometer (Figure 3.2 A).
Algometry is a reliable method for evaluating pressure-pain thresholds (PPTs)
both within and between sessions (Potter et al., 2006, Vanderweeën et al., 1996,
Nussbaum and Downes, 1998, Frank et al., 2013). PPT is defined as the
minimum pressure required to induce pain (Nussbaum and Downes, 1998).
Evaluation of PPTs both local and remote to injured tissue provides valuable
information about central compared to peripheral mechanisms contributing to a
painful experience (Graven-Nielsen and Arendt-Nielsen, 2002, Curatolo et al.,
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2001) and is recommended for inclusion in tendinopathy populations (Kregel et
al., 2013).
PPT familiarization involved practice repetitions over the nailbed of the left
2nd digit and included emphasis that the measurement was not a test of pain
tolerance but rather the point at which the pressure sensation was first perceived
as painful. Measurements were completed at three sites: (1) the Achilles tendon,
using the pinch handle 4 cm proximal to the calcaneal insertion; (2) the ipsilateral
medial gastrocnemius, measured at the midpoint between its lateral and medial
margins along the location of largest calf girth; and (3) the upper trapezius, along
its superior margin halfway between the seventh cervical vertebrae and the
acromion process (see Figure 3.2). For all PPT measurements, the probe tip was
maintained in a position orthogonal to the tissue being tested. Participants
pressed a button when the pressure sensation was first perceived as painful
(Rakel et al., 2014). Two measurements were completed at each measurement
site, and the average of the two measurements was used in subsequent
analyses. Measurement order was randomized for each leg, participant, and
session.
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Figure 3.3. Representative torque data from a male participant during
maximal voluntary isometric contraction (isometric MVC). Measurements
included: superimposed twitch (SIT) and resting twitch (RT).

Isometric Strength, Voluntary Activation and Contractile Properties
Isometric MVCs were repeated with the addition of a superimposed
doublet stimulation (SIT, superimposed twitch) followed by a resting
(potentiated), 100 Hz doublet stimulation (RT, resting twitch) of the tibial nerve at
~2 seconds after the isometric MVC (Figure 3.3). Doublet stimulations were used
for the SIT, as this has been shown to be more sensitive than a single stimulation
(Rozand et al., 2020, Oskouei et al., 2003). The forces during the SIT and RT
were used in the analysis of voluntary activation and resting twitch torque (see
Data Analysis). Each participant performed four isometric MVCs with two minutes
of rest between each trial.
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Dynamic Strength
Concentric MVCs were performed at five velocities: 30, 60, 90, 120, and
150 deg/s. Velocities faster than 150 deg/s were not utilized, because pilot
testing revealed that most healthy participants could not reach a velocity plateau
at those target velocities within their available ankle range of motion. Eccentric
MVCs were completed at three velocities: 30, 60, and 90. During pilot testing,
eccentric velocities greater than 90 deg/s resulted in no further change in torque
(i.e., participants reached a torque plateau by 90 deg/s). Concentric and
eccentric MVCs were completed using each participant’s available range of
motion. Familiarization included four repetitions of concentric MVCs and four
repetitions of eccentric MVCs at 60 deg/s. Test contractions included four
repetitions of maximal-effort contractions at each of the velocities listed above.
Order of velocity was randomized for each limb of every participant. Participants
were given one minute rest between each set of maximal-effort contractions.
Strong verbal encouragement and visual feedback were provided for every
strength measurement in the study, including familiarization repetitions.

Data and Statistical Analyses
The best of four efforts was used for each of the maximal strength efforts
(isometric, concentric, and eccentric MVCs). Isometric MVC was measured as
the average of a 0.5-second window surrounding the maximum torque but
preceding the superimposed electrical stimulation. Concentric and eccentric
MVCs were measured as the instantaneous peak torque during dynamic
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contractions. Peak power was calculated as the product of instantaneous peak
torque and the velocity at time of peak torque. Voluntary activation was
calculated as the ratio of the superimposed twitch (SIT) torque to the resting
doublet twitch (RT) during the MVIC (Gandevia, 2001): (1-SIT/RT)*100. The
resting twitch refers to the torque amplitude of the electrically-evoked, potentiated
resting doublet stimulation that occurred immediately after an MVIC.
Independent samples t-tests were used to compare physical
characteristics, physical activity levels, and kinesiophobia between groups.
Multivariate analyses of covariance (MANCOVAs) were used to evaluate the
between-group effects of AT diagnosis on the dependent variables (strength,
voluntary activation, and resting twitch amplitude), with covariates of biological
sex and age. Mediation analyses were performed to evaluate effects of AT on
PPT and any subsequent effects of PPTs on strength, neural drive, and resting
twitch amplitude. Repeated-measures ANCOVAs were used to compare the
more and less affected (or unaffected) limbs of persons with AT using a similar
approach: outcome variables of strength, neural drive, and resting twitch;
mediation analysis using pressure-pain thresholds. For all ANOVAs,
Greenhouse-Geisser corrections were used whenever the assumption of
sphericity was violated.
Regression analyses were completed to assess the contributions of
muscle properties, neural drive, and pain to maximal isometric strength.
Normality was assumed for all variables based on histograms and Q-Q plots.
Significance was determined a priori at p < 0.05. Data are reported as mean ±
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standard deviation (SD) in the text and displayed as mean ± standard error of the
mean (SEM) in the figures. All analyses were performed in IBM Statistical
Package for Social Sciences (SPSS, V26).

RESULTS

Subjects
Seven of the 14 AT participants who participated had unilateral AT, while
seven had bilateral AT. Thus, limbs were divided into “more affected” and “less
affected” when completing within-group analyses. Limbs were matched for
dominance for between-group analyses (comparing the more affected limb in AT
to control limbs). In the more affected AT limbs, symptom duration ranged
between 3 and 240 months. Despite attempts at matching based on age and sex,
the AT group was older and had a greater proportion of males than the control
group (Table 3.1). Consequently, age and sex were used as covariates in
statistical analyses (see above) and torque data were normalized to body weight.
There was insufficient power to analyze interactions between sex and group and
differences between more affected, less affected, and unaffected limbs in AT.
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Table 3.1. Demographics of the test groups.: control; AT group, more
affected limb; and AT group, less affected limb.
Variable

Control

AT more
affected

p-value,
C vs AT

AT less
p-value
affected more vs less

14
14
[7 male]
[10 male]
0.26
Age (yrs)*
23.6±5.5
31.0±11.1
0.04
Height (m)
1.48±0.11 1.52±0.09
0.31
Weight (kg)*
67.4±13.0 87.7±21.3
0.01
Fat mass (%)
24.1(10.5) 27.5(11.2)
0.41
Lean mass (%)
72.3(9.3) 69.6(10.6)
0.48
BMI (kg·m ̄ ²)*
22.9±2.0
28.5±7.1
0.01
MAQ (met*hr/wk)
35.1(26.2) 59.6(53.6)
0.15
TSK
32.9(6.9)
36.6(9.7)
0.29
Symptom duration (mos)
0 (0.0)
66.9 (67.0) 0.002
FAAMadl (%)*
99.2(1.6) 82.1(18.9) 0.005 93.3(10.9)
§
VISA-A (%)*
99.2(2.9) 63.0(17.9) <0.001 78.1(20.5)
§
FAAMsport (%)*
98.1(3.0) 61.7(16.7) <0.001 86.5(14.2)
§
*p<0.05 between groups; p<0.05 within AT group
N

0.067
0.048
<0.001

Self-Reported Pain and Disability
Pain and disability were significantly greater in the more affected AT limb,
whether when compared to controls or to the less affected AT limb, based on
each the FAAM activities of daily living subscale, the FAAM sport subscale, and
the VISA-A (Table 3.1). Kinesiophobia did not differ between groups (range of
values: AT, 26-54; controls, 25-46).

Isometric Plantar Flexor Strength
Isometric MVC torque of the plantar flexor muscles was not different
between AT and controls, whether normalized to body weight (AT: 1.65(0.59)
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Nm/kg; C: 1.77(.030) Nm/kg; p=0.472; Figure 3.4) or considered in isolation with
body weight as a covariate (AT: 140.45(47.70) Nm; C: 120.47(36.64) Nm;
p=0.954). There were no group differences when controlling for sex (p=0.171). In
persons with AT, isometric MVC torque was not different between the more
affected and less affected limbs (less affected AT: 151.59 (45.83); p=0.534).

Figure 3.4. Maximal isometric plantar flexor torque, normalized to body weight.
There were no differences either between the more affected limb in AT and the
matched-dominance limb in controls (p=0.472) or the more and less affected limbs in
AT participants (p=0.534).

Dynamic Strength & Power of the Plantar Flexor Muscles
Concentric and eccentric MVC torque was not different between groups at
any of the dynamic velocities, whether pooled across different velocities
(p=0.127) or at individual velocities (Table 3.2; Figure 3.5) when controlling for
age and sex. There was a main effect of velocity for both torque (p=0.028) and
power (p<0.001). Power was not different between groups when analyzed
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collectively across velocities (p=0.838) or at individual velocities (Table 3.3;
Figure 3.6) when controlling for age and sex.
When comparing the more and less affected limbs in AT, there were no
differences in concentric and eccentric MVC torque (p=0.598) or power
(p=0.966). When analyzed at individual velocities, the findings were similar:
maximal dynamic (concentric and eccentric) plantar flexor strength was not
different between more affected and less affected (or unaffected) limbs in AT.
There was a main effect of velocity on both torque (p<0.001) and power
(p<0.001).

Table 3.2. Peak plantar flexor torque during concentric and eccentric
velocities. Comparisons between groups (control versus more-affected AT)
and within the AT group (more versus less affected limb) are included.
Velocity
(deg/s)
-90
-60
-30
30
60
90
120
150

Torque (Nm/kg)
AT more
AT less
affected
affected
2.14(0.63) 1.93(0.79) 1.91(0.75)
1.80(0.33) 1.59(0.57) 1.84(0.79)
1.87(0.74) 1.45(0.51) 1.83(0.81)
1.51(0.26) 1.24(0.54) 1.28(0.49)
1.22(0.26) 1.01(0.42) 1.02(0.41)
0.99(0.27) 0.83(0.35) 0.89(0.34)
0.88(0.20) 0.73(0.30) 0.76(0.30)
0.85(0.23) 0.75(0.28) 0.72(0.28)
Control

p-values
C vs AT
AT more
more
vs less
0.235
0.949
0.427
0.345
0.057
0.147
0.148
0.808
0.181
0.974
0.308
0.700
0.246
0.809
0.474
0.784
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Table 3.3. Peak plantar flexor power during concentric and eccentric
velocities. Comparisons between groups (control versus more-affected AT)
and within the AT group (more versus less affected limb) are included.
Velocity
(deg/s)
-90
-60
-30
30
60
90
120
150

Control
-3.06(0.81)
-2.10(0.45)
-1.13(0.26)
0.77(0.18)
1.26(0.30)
1.58(0.46)
1.63(0.53)
1.73(0.69)

Power (W/kg)
AT more
affected
-2.75(1.16)
-1.87(0.76)
-0.97(0.39)
0.64(0.28)
1.06(0.43)
1.29(0.58)
1.35(0.74)
1.49(0.95)

AT less
affected
-2.81(1.12)
-1.87(0.79)
-0.94(0.41)
0.67(0.25)
1.06(0.43)
1.34(0.56)
1.39(0.74)
1.37(0.93)

p-values
C vs AT AT more vs
more
less
0.324
0.889
0.197
0.998
0.110
0.821
0.246
0.783
0.239
0.989
0.259
0.810
0.383
0.897
0.351
0.738
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Figure 3.5. Plantar flexor torque-velocity relationship, normalized to body
weight. There were no differences either between the more affected limb in AT
and the matched-dominance limb in controls (p=0.127) or the more and less
affected limbs in AT participants (p=0.598).

Figure 3.6. Maximal plantar flexor power at each dynamic velocity,
normalized to body weight. There were no differences either between the more
affected limb in AT and the matched-dominance limb in controls (p=0.838) or the
more and less affected limbs in AT participants (p=0.966).

72
Voluntary Activation & Contractile Function
Resting twitch amplitude, a measure of contractile function, was
significantly different between groups when controlling for age and sex (C:
0.48(0.07) Nm/kg; more affected AT: 0.38(0.12) Nm/kg; p=0.001; Figure 3.7).
Resting twitch amplitude was not different between limbs in persons with AT
(less effected AT: 0.44(0.12) Nm/kg; p=0.267). There were no differences in
voluntary activation between groups, controlling for age and sex (p=0.546), or
between limbs (p=0.351; C: 81.74(20.32)%; more affected AT: 82.32(20.01)%,
less affected AT: 88.51(13.90)%; Figure 3.8).

Figure 3.7. Plantar flexor resting twitch amplitude, normalized to body
weight, in people with AT compared to healthy controls. Resting twitch torque
was lower in the more affected limb in AT compared to the matched-dominance
limb in controls (p=0.001). There were no differences between the more and less
affected limbs in AT participants (p=0.267). *p<0.01
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Figure 3.8. Voluntary activation of the plantar flexor muscles in people with
AT and healthy controls. There were no differences in voluntary activation of
the plantar flexor muscles, either between the more affected limb in AT compared
to the matched-dominance limb in controls (p=0.546) or between the more and
less affected limbs in AT participants (p=0.351).

Pain
Upper trapezius PPTs were higher in the more affected limb in AT when
compared with controls (AT: 327.86(184.60) kPa; control: 189.82(73.31) kPa;
p=0.015; Figure 3.9). This difference remained significant whether adjusting for
age (p=0.019), sex (p=0.033) or physical activity (p=0.046). However, it was not
significant when adjusting for body weight alone (p=0.202) or for the combined
variables of physical activity, age, sex and body weight (p=0.393). There were no
differences in calf (AT: 258.86(156.51) kPa; control: 197.14(109.53) kPa;
p=0.238) or Achilles tendon PPTs (AT: 268.18(136.78) kPa; control:
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229.86(97.26) kPa; p=0.401, respectively; Figure 3.9), even when controlling for
sex, age, body weight, and physical activity (calf, p=0.934; Achilles tendon,
p=0.650). The more and less affected limbs in AT were not different at the upper
trapezius (less affected AT: 334.25(181.44), p=0.927), calf (less affected AT:
285.21(158.22), p=0.661) or Achilles tendon (less affected AT: 300.82(142.74),
p=0.542).

Figure 3.9. Pressure-pain thresholds (PPTs) at the medial gastrocnemius
(MG), Achilles tendon (AT), and upper trapezius (UT) in AT compared with
controls. MG and AT PPTs were not different between the more affected AT limb
and the matched-dominance limb in controls (p=0.238 and p=0.401, respectively).
UT PPTs were higher in AT compared to controls (p=0.015). *p<0.05

Predictors of Isometric MVC Strength
Predictors for isometric MVC strength included in the regression analysis
were: RTA, VA, and upper trapezius PPT. Because local pain levels (Achilles
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tendon and calf PPTs) did not differ between groups, only upper trapezius PPTs
were included in this analysis.
In healthy controls, the set of predictors (RTA, VA, and upper trapezius
PPT) significantly contributed to isometric MVC: F(3,10)=3.93, p=0.043.
However, when controlling for other predictors, VA was the only predictor of
isometric MVC in controls, t(10)=2.70, p=0.022. The proportion of variance
uniquely explained by VA (sr2) in healthy controls was 0.33. The set of three
predictors also significantly contributed to isometric MVC in the more affected
limb in AT: F(3,10)=9.11, p=0.003. When controlling for other predictors, only
RTA significantly predicted isometric MVC in the more affected limb in people
with AT: t(10)=4.65, p=0.001. The proportion of variance uniquely explained by
RTA (sr2) in the more affected limbs of persons with AT was 0.58. In the less
affected limb in AT, the set of predictors significantly contributed to isometric
MVC: F(3,10)=7.29, p=0.007. When controlling for the other predictors, both VA
(t(10)=2.29, p=0.045) and RTA (t(10)=2.98, p=0.014) were significant predictors
of MVC torque in the less affected limb in people with AT. The proportional
variance uniquely explained by these predictors, in the less affected AT limb,
were as follows: sr2=0.16 for VA and sr2=0.28 in RTA.

DISCUSSION

This is the first study to evaluate the neural and muscular contributions to
maximal strength in people with AT. We showed that the contribution differed
between healthy controls and people with AT, despite similar maximal isometric,
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concentric, and dynamic plantar flexor strength between groups and legs. People
with AT had lower involuntary evoked twitch amplitude than controls, both in the
more- and less-affected AT limbs. Accordingly, the twitch amplitude was
associated with MVIC strength in people AT, indicating contractile function
predicted their strength. In contrast, voluntary activation, thus neural drive, was
the largest predictor of plantar flexor MVIC in healthy controls. Furthermore,
systemic pain perception differed between groups, because persons with AT had
elevated pressure-pain thresholds of the upper trapezius, despite similar
pressure-pain thresholds at the Achilles tendon and medial gastrocnemius
muscle.

Strength in AT
There were no differences in maximal plantar flexion strength, whether
between limbs in persons with AT or between AT and healthy controls. While
strength differences are commonly assumed in tendinopathy (O'Neill et al.,
2016), a recent systematic review (Hasani et al., 2021) found conflicting evidence
for impaired plantar flexor muscle strength in people with AT compared with
healthy controls. When comparing between limbs in persons with AT, Hasani et
al. (2021) concluded that there was limited to moderate evidence for decreased
plantar flexor strength in the affected limb in people with AT. Supporting these
conclusions, we showed the plantar flexor strength and power in people with AT
was not impaired at any velocity.
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Strength values obtained in this study were within normative ranges
reported for healthy adults in their second through fourth decades (McKay et al.,
2017, Danneskiold-Samsøe et al., 2009). Voluntary activation data similarly were
within expected ranges for the plantar flexor muscles (Shima et al., 2002).
Together, these suggest that participants provided maximal effort during
measurements for maximal isometric plantar flexor strength and were
appropriately familiarized to the task.

Neural and Muscular Factors in AT
Voluntary activation was the best predictor of isometric MVC torque in
healthy controls. However, this index of neural drive had a lesser influence on
isometric MVC torque with greater symptom severity: at the proportional variance
in isometric MVC uniquely explained by VA decreased from 0.33 in healthy
controls, to 0.28 in the less-affected limb in AT, to 0.01 in the more affected limb
in AT. In contrast, muscular (contractile) mechanisms were the best predictor of
isometric MVC torque in the more affected limb in AT. Muscular mechanisms
played an increasingly prominent role in predicting isometric MVC as symptom
severity increased: the proportional variance in isometric MVC that was uniquely
explained by RT increased from 0.02 in controls, to 0.28 in the less-affected limb,
to 0.58 in the more affected limb in AT.
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Pain Pressure Thresholds in AT
Persons with AT had greater upper trapezius PPT when compared to
healthy controls, while PPTs at the calf and Achilles tendon were not different.
Thus, persons with AT were less sensitive to pain than controls in a region of the
body not involved in the AT injury. These findings suggest a difference in
systemic pain modulation, despite similar local pain modulation. However, it is
important to note the apparent trend of higher PPTs at all sites – perhaps not
limited to the upper trapezius – in persons with AT. While not significant at the
Achilles tendon and medial gastrocnemius, this could simply be the result of
insufficient power to detect group differences at these sites. Importantly, a trend
toward greater PPTs globally could be a reflection of increased body weight and
increased number of male participants in the AT group, rather than a reflection of
meaningful differences in PPTs between AT and controls.
Altered central pain processing in AT has been previously described
(Eckenrode et al., 2019, Tompra et al., 2016), based on lower pressure-pain
thresholds when measured at a remote site. In contrast, Plinsinga et al. (2018)
found no differences in PPTs at either their remote site (the lateral elbow) or over
the affected tendon when comparing AT to controls (Plinsinga et al., 2018).
However, neither of these studies limited their test group to midportion AT; they
included insertional AT (Tompra et al., 2016, Eckenrode et al., 2019, Plinsinga et
al., 2018), persons with lateral ankle pain and persons with heel pain (Tompra et
al., 2016). The heterogeneity of findings suggests that AT may be too
multifactorial to simplify into central versus peripheral processes.
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Often, the impact of pain on motor output is thought to be inhibitory,
whereby pain inhibits motor pathways (Hodges and Moseley, 2003). However,
the relationship between pain and motor output can be far more complex
(Hodges, 2011), including a redistribution of motor commands within and
between muscles. Such a complex relationship could explain why maximal
plantar flexor torque was similar between groups, despite diminished contractile
function in people with AT: perhaps, in response to pain, motor commands are
redistributed to optimize recruitment of agonist muscles innervated by the
superficial fibular nerve. It is not possible to make a definitive conclusion
regarding this theory, however, as the fibularis muscles and superficial fibular
nerve were not evaluated in this study.
In this study, persons with AT reported being highly active per the MAQ,
including in activities commonly associated with onset of AT (such as running
and jumping sports). One possible explanation for continued participation – and
at such high levels, no less – is that central pain mechanisms dampen any painrelated signaling, effectively “protecting” these people from symptoms (a
phenomenon previously reported, (Rio et al., 2018)). In this way, the decreased
sensitivity to pain observed in this study (measured by increased upper trapezius
pressure-pain thresholds) may have enabled people with AT to continue
participating in activities, even if those activities result in further damage to the
Achilles tendon. However, reduced sensitivity to painful stimuli, while
advantageous in the short term (i.e., for enabling continued participation in
activities), could prove detrimental in the long run, resulting in constant re-injury
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to the tendon and possibly resulting in eventual tendon rupture (Rio et al., 2018,
Noback et al., 2018).

Limitations
Possible neural and muscular mechanisms for any differences in strength
with AT were investigated during isometric contractions only. The interpolated
twitch technique is not well-validated during dynamic contractions (Klass et al.,
2007, Rozand et al., 2017), thereby limiting our application to the eccentric and
concentric contractions. This does not change comparisons between groups or
limbs. However, neural drive and muscular mechanisms cannot be assumed to
behave identically during dynamic as during isometric contractions.
Diagnosis in this study was based upon clinical evaluation. While imaging
can provide confirmation of pathologic changes within the tendon (Puddu et al.,
1976, Maffulli et al., 1998), it does not correlate well with symptoms (Docking et
al., 2015a, van Dijk et al., 2011, Cook et al., 2001, Rompe et al., 2007).
Importantly, variability in the quality of the Achilles tendon, when evaluated based
on imaging findings, is partially explained by age, BMI, and physical activity
(Docking, 2021a, Kannus and Jozsa, 1991). Thus, in this study, any identified
differences in tendon quality as assessed via imaging may simply be a byproduct
of the older, heavier AT group.
Supramaximal stimulation is an important prerequisite when evaluating
neural drive and contractile mechanisms. However, complete activation of all
plantar flexor muscles would require simultaneous stimulation of the superficial
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fibular nerve and tibial nerve, while avoiding activation of the deep fibular nerve.
Even proximity of the stimulating electrode to either the sciatic or deep fibular
nerve can result in inadvertent stimulation of the antagonist muscles. This is
particularly problematic at higher (supramaximal) stimulation intensities.
Therefore, there is a potential that supramaximal stimulation levels resulted in
inadvertent activation of dorsiflexors. As this would impact controls and persons
with AT similarly, however, it is unlikely this would change the between-group
results as reported in this study.
The control and AT groups in this study were not matched for age, body
weight, or sex. However, analyses were unchanged when normalizing torque to
body weight and when adding age and sex as covariates. This applied for all
between-group measurements, including MVCs, VA, RT, and PPT.
Finally, this study cannot attribute cause and effect to the altered muscular
mechanisms (impaired RT) or differences in systemic pain modulation (elevated
upper trapezius PPT) seen in persons with AT. Further research – and
alternative study designs – would be required to establish causation.

Conclusions
Plantar flexor strength and power differences cannot be assumed in
persons with AT, regardless of whether these are evaluated isometrically,
concentrically, or eccentrically. Despite similar maximal strength and power,
however, there were underlying impairments within the triceps surae muscle
group of people with AT compared with controls. These findings suggest that
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prognosis in AT may not depend upon making gains in plantar flexor strength or
power, a finding echoed by a recent systematic review (Hasani et al., 2021).
Instead, symptom resolution may be contingent upon normalizing function of the
triceps surae, not emphasizing strength and power of the entire plantar flexor
group.
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CHAPTER 4 : PLANTAR FLEXOR FATIGABILITY IN ACHILLES
TENDINOPATHY
INTRODUCTION

Midportion Achilles tendinopathy is an overuse condition resulting in pain
and stiffness localized to the middle of the tendon (between 2 and 6 centimeters
proximal to the calcaneal insertion). It is commonly assumed either to be caused
by or to result in endurance deficits of the plantar flexor muscles. However, the
role of fatigability in AT – and the contributing mechanisms – are poorly
described.
Fatigability can be understood as either performance fatigability or
perceived fatigability (Enoka and Duchateau, 2016). Perceived fatigability is a
symptom measured by self-report. In contrast, performance fatigability is an
objective measure that quantifies the decline in motor performance over time. It
can be quantified as the number of repetitions completed prior to task failure
(Hunter et al., 2004b), such as number of heel-raise repetitions completed in the
Single-Leg Heel Raise test (Hislop et al., 2013). In a laboratory setting, fatigability
is often measured as an acute reduction in either force or power following
fatiguing exercise (Enoka and Duchateau, 2008, Gandevia, 2001). Fatigability
can be evaluated in response to isometric or dynamic exercise.
In clinical and research settings, the Single-Leg Heel Raise test (SLHR) is
recommended for evaluating activity limitations and prognosis in AT (Martin et
al., 2018). The SLHR was designed for the purpose of measuring plantar flexor
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strength within physical therapy manual muscle testing protocol (Hislop et al.,
2013). However, when performed as originally designed and instructed, it lacks
sufficient construct validity (Harris-Love et al., 2014, Hébert-Losier et al., 2009,
Sara et al., 2021).
Mechanisms contributing to fatigability include contractile properties
(measured as the electrically-evoked twitch torque in a resting muscle) and
neural drive (voluntary activation measured using the interpolated twitch
technique) (Gandevia, 2001). These mechanisms differ in their contribution to
fatigability between populations, muscle groups, and tasks (Avin and Frey Law,
2011, Senefeld et al., 2018b, Hunter et al., 2004a). In people with AT, it is
possible that the contributions of the neural and contractile mechanisms that lead
to reductions in force in response to a fatiguing task could differ to healthy
controls. We reported in aim 2 (chapter 3), for example, that people with AT were
similar in maximal strength and power to that of healthy controls, but that
contractile function was lower and was associated with pain perception. The
impact of pain and the effects on motor output during repeated voluntary
fatiguing contractions are not known in people with AT. Furthermore, the
contribution of the neural and contractile mechanisms to fatigability is not
understood in people with AT.
The purpose of this study was to evaluate performance fatigability of the
plantar flexors with two different tasks (1) a dynamic and clinically-based task
(SLHR) that involves repetitions completed during to failure, and (2) in response
to a single bout of maximal isometric contractions. Contractile properties, neural
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drive, and pain were quantified to understand the mechanisms of plantar flexor
fatigability in people with AT.

MATERIALS & METHODS

Participants
Twenty-eight participants volunteered to participate in this study (14 with
AT, 14 controls; see Table 4.1). Inclusion criteria included the following: gradual,
insidious onset of pain and/or stiffness at the midportion of the Achilles tendon,
which had persisted for at least 3 months; and healthy controls without history of
either pain or stiffness in the Achilles tendon region. AT diagnosis was a clinical
diagnosis based on localized tendon pain 2-6 cm proximal to the calcaneal
insertion, a positive Royal London Hospital Test (Maffulli et al., 2003), thickening
at the midportion of the tendon, and a positive Arc Sign (Reiman et al., 2014).
Exclusion criteria included known cardiovascular disease, neurological disease,
and any acute injury, bursitis, insertional tendinopathy, or osteoarthritis in either
lower extremity. Informed consent was obtained from all participants prior to
participation in the study. The study protocol was approved by the Marquette
University Institutional Review Board and in compliance with the Declaration of
Helsinki.
All testing took place during three sessions and was performed on both
lower extremities. All data collection was led by the same researcher (LKS). The
first session involved familiarization, clinical measurements, and self-report
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outcome measures evaluating pain, disability, and fear of movement (Foot and
Ankle Ability Measure (FAAM) (Martin et al., 2005); Victoria Institute of Sport
Assessment-Achilles Questionnaire (VISA-A) (Robinson et al., 2001), and Tampa
Scale of Kinesiophobia (TSK) (French et al., 2007)). Physical activity data were
calculated based on responses to a 12-month self-report physical activity
questionnaire, the Modifiable Activity Questionnaire (MAQ) (Kriska, 1997). The
second session involved performance of the single-leg heel raise (SLHR) to task
failure. The third session evaluated performance during the isometric fatiguing
exercise task. In brief, the third session involved measures of maximal isometric
strength (MVIC), voluntary activation and contractile properties of the plantar
flexor muscles, perceived pain, rating of perceived exertion (RPE) and painpressure thresholds (PPTs) while seated in a Biodex dynamometer (Biodex
System 3 Pro; Biodex Medical; Shirley, NY) before, during, and after a maximaleffort isometric fatiguing protocol performed for four minutes. The order of the
second and third sessions was randomized.

Single-Leg Heel Raise
The SLHR was completed as is done in clinic (Hislop et al., 2013) and as
is described in chapter 2, with participants performing as many SLHR repetitions
as possible prior to task failure. This involved repeated heel raises while standing
on one leg. Participants completed these at a standardized pace of one heel
raise every three seconds using the assistance of an audible metronome and
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verbal cueing. Participants were provided light fingertip support in the horizontal
plane to assist with maintaining balance during the task.
Setup and familiarization were completed earlier in the same session.
Setup involved positioning a horizontal target plate to the maximum height
achievable by each participant during a single-leg heel raise. Practice repetitions
were performed using the metronome. Once proficiency was demonstrated
during task familiarization, the SLHR was completed. Task failure was defined as
two consecutive missed repetitions of the target plate and/or inability to continue
at the prescribed pace. The number of repetitions prior to failure was recorded.

Isometric Fatiguing Exercise Task: Experimental Setup
Participants were seated in a Biodex System 3 Pro dynamometer with the
knee in neutral extension (0 degrees) and the trunk reclined 35 degrees. The
trunk position was chosen to minimize the influence of hamstring tightness and
sciatic nerve tension of the test limb. The test foot was positioned on a foot plate
affixed to the dynamometer (Figure 3.1). To minimize extraneous movement and
isolate exercise to the ankle joint, straps were placed across the waist, chest,
and ipsilateral thigh. Two straps were used around the ankle and one around the
forefoot to maintain the plantar surface of the foot in contact with the foot plate.
The test ankle was placed in a neutral position (0 degrees), with the foot
perpendicular to the shank. The order of limbs was randomized every session.
PPTs were measured at the Achilles tendon, ipsilateral medial gastrocnemius,
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and upper trapezius. Testing order for PPTs was randomized every session for
each limb.

Baseline Measures
Preliminary testing involved MVICs of the plantar flexors with two-minutes
rest between trials. Each participant performed at least two trials, repeating these
until no further torque increases resulted (determined as two MVICs within 5% of
each other). The highest torque achieved during these repetitions was used to
establish a torque target for the electrical stimulation procedure that followed.
The ipsilateral tibial nerve was stimulated using a constant-current,
variable high-voltage stimulator (DS7AH; Digitimer Ltd; Hertforshire, UK) to
evoke contractions at rest and during MVICs. Stimulation was applied to the
ipsilateral tibial nerve using a bar electrode at the medial popliteal space distal to
the sciatic nerve bifurcation. Single square-wave pulses (400 V, 100µs duration)
were delivered with a stimulation intensity initiated at 50mA and gradually
increased until a plateau was reached, such that further increases in stimulation
intensity resulted in no additional changes in evoked torque (Senefeld et al.,
2018b, Sundberg et al., 2018b). The plateau intensity was increased further by
10% to achieve a supramaximal stimulation. This stimulation intensity was used
during a single pulse stimulation and double pulse of stimulation (at 100Hz) to
enable assessment of contractile properties and voluntary activation,
respectively, of the plantar flexor muscles.

89
MVICs were repeated four times with the addition of both a superimposed
doublet stimulation (SIT, superimposed twitch) and a post-activation, resting
(potentiated) doublet stimulation (RT, resting twitch) of the tibial nerve ~2
seconds after the MVIC. Doublet stimulations were used for the SIT, as this has
been shown to be more sensitive (Rozand et al., 2020, Oskouei et al., 2003) .
The forces during the SIT and RT were used in the analysis of voluntary
activation and resting twitch torque (see Data Analysis). Two minutes of rest
were provided between each repetition of MVIC with electrical stimulation.

Perceived Pain and Exertion
The Numeric Pain Rating Scale was used to evaluate perceived calf and
Achilles tendon pain, where 0 is no pain and 10 is the worst pain imaginable. The
10-point Borg Rating of Perceived Exertion (RPE) Scale was used to evaluate
perceived exertion in the exercising calf and tendon. Participants were
familiarized to both measurement scales during the familiarization session.
Reference scales were posted below the feedback monitor during all sessions. At
the start of the second session, participants were asked to rate baseline pain and
RPE. They were also instructed to consider the maximum calf pain and RPE
experienced during the fatiguing task and that these would be recorded
immediately following the fatiguing task. Achilles tendon pain was reported every
minute during the fatiguing task.
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Pressure-Pain Thresholds
Pressure-pain threshold (PPT) refers to the minimum pressure required to
induce pain (Nussbaum and Downes, 1998). PPTs were measured using an
algometer (Somedic SenseLab AB, Sweden) with a 1cm 2 probe tip at an
application rate of 30 kPa/s. Algometry is a reliable method for evaluating
pressure-pain thresholds (PPTs) both within and between sessions (Potter et al.,
2006, Vanderweeën et al., 1996, Nussbaum and Downes, 1998, Frank et al.,
2013). Evaluation of PPTs both local and remote to injured tissue provides
valuable information about central compared to peripheral mechanisms
contributing to a painful experience (Graven-Nielsen and Arendt-Nielsen, 2002,
Curatolo et al., 2001) and is recommended for inclusion in tendinopathy
populations (Kregel et al., 2013).
PPT familiarization involved practice repetitions over the nailbed of the left
2nd digit and included emphasis that the measurement was not a test of pain
tolerance but rather the point at which the pressure sensation was first perceived
as painful. Measurements were completed before and after fatiguing exercise at
three sites: (1) the Achilles tendon, using the pinch handle 4 cm proximal to the
calcaneal insertion; (2) the ipsilateral medial gastrocnemius, measured at the
midpoint between its lateral and medial margins along the location of largest calf
girth; and (3) the upper trapezius, along its superior margin halfway between the
seventh cervical vertebrae and the acromion process. For all PPT
measurements, the probe tip was maintained in a position orthogonal to the
tissue being tested. Participants pressed a button when the pressure sensation
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was first perceived as painful (Rakel et al., 2014). Two measurements were
completed at each measurement site during each timepoint (i.e., at baseline and
immediately following the fatiguing exercise task). The average of the two
measurements was used in subsequent analyses. Measurement order was
randomized for each leg, participant, and session.

Figure 4.1. Representative torque data from a male AT participant during the
intermittent MVIC task. The task involved four sets of fourteen MVICs, the first of
which included electrical stimulation during (SIT) and after (RT) the MVIC. An
additional MVIC with stimulation was completed immediately following the task

Isometric Fatiguing Exercise Task
Participants were familiarized to the isometric fatiguing exercise prior to
initiating the task. This included instruction, demonstration, and practice
repetitions at a submaximal level with sample verbal cues and encouragement.
The task was not initiated until the participant could demonstrate several
repetitions, including a repetition with mock stimulation, without error.
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The fatiguing exercise involved four, 1-minute sets of 14 repetitions of
intermittent MVICs while seated in the Biodex dynamometer. The intermittent
MVICs were performed in a 2:2 duty cycle: 2 seconds of maximal contraction
followed by 2 seconds of rest, repeated for 13 repetitions without stimulation.
MVICs with superimposed and resting electrical stimulations were performed
before each 13-repetition set and again at the end of the 4-minute task, for a total
of 14 MVIC repetitions per set with one immediate post-task MVIC. Therefore, a
total of 57 MVICs (52 without stimulation; 5 with stimulation) were completed
during the 4-minute task (see Figure 4.1). The repetitions that included electrical
stimulation included an additional 4 seconds of rest following the resting
stimulation. During these 4 seconds, the participants were asked (1) whether the
MVIC during electrical stimulation was a maximal attempt, and (2) what their
perceived tendon pain was at that time (per NPRS). Strong verbal
encouragement was provided for every repetition and real-time visual feedback
was provided using a feedback monitor.

Data and Statistical Analyses
For all analyses of strength, contractile properties, and voluntary
activation, “baseline” refers to the values that correspond to the baseline MVIC
that yielded the greatest torque amplitudes. “Post-task” refers to the MVIC
immediately following completion of the isometric fatiguing exercise. All torque
measurements (including MVIC and RT at all timepoints) were normalized to
body weight.
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MVIC was measured as the average of a 0.5-second window surrounding
the maximum torque. Voluntary activation was calculated as the ratio of the
superimposed to the resting doublet twitch (Gandevia, 2001): (1-SIT/RT)*100.
Resting twitch refers to the torque amplitude of the electrically-evoked
potentiated resting doublet stimulation that occurred immediately after an MVIC.
Fatigability was quantified as the reduction in MVIC from baseline to immediately
following the isometric fatiguing exercise task.
Independent samples t-tests were used to compare physical
characteristics, physical activity levels, SLHR repetitions, and Kinesiophobia
between groups. Analysis of covariance was used to evaluate group differences
in the following baseline variables, controlling for sex and age: MVIC torque,
electrically-evoked resting twitch amplitude (RT), voluntary activation (VA), pain,
RPE, and PPT. Repeated-measures analysis of variance (RM-ANOVA) was
used to evaluate those same variables between limbs in persons with AT. RMANOVA was used to evaluate changes in MVIC torque, RT, VA, pain, RPE, and
PPT across the fatiguing exercise, using time as the within-subjects factor and
diagnosis as the between-subject factor, controlling for age and sex between
groups. Greenhouse-Geisser corrections were used whenever the assumption of
sphericity was violated. Mediation analyses were utilized to evaluate the impact
of pain on the relationships between diagnosis and muscle function (MVIC, VA,
and RT) (Field-Fote, 2019).
Regression analysis was used to evaluate which variables (PPT, VA, RT)
predict fatigability in the isometric fatiguing task. Normality was assumed for all
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variables based on histograms and Q-Q plots. Significance was determined a
priori at p < 0.05. Data are reported as mean ± standard deviation (SD) in the text
and displayed as mean ± standard error of the mean (SEM) in the figures. All
statistical analyses were completed using IBM Statistical Package for Social
Sciences (SPSS, V26).

RESULTS

Participants
Seven of the 14 AT participants who participated had unilateral AT, while
seven had bilateral AT. For within-group analyses, limbs in persons with AT were
divided into “more affected” and “less affected” limbs. Limbs were matched for
dominance for between-group analyses (comparing the more affected limb in AT
to control limbs). The AT group was older, heavier, and included a greater
proportion of male participants, despite attempts at matching based on age and
sex (Table 1). Consequently, age and sex were used as covariates in statistical
analyses (see above) and torque data were normalized to body weight. There
was insufficient power to analyze interactions between sex and group and
differences between more affected, less affected, and unaffected limbs in AT.
The AT group scored lower (worse pain and function) on the FAAM (both
ADL and Sport subscales) and the VISA-A. The more-affected limb scored lower
(greater disability) on the VISA-A and Sport subscale of the FAAM, when
compared to the less-affected limb. (Table 1)
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Table 4.1. Demographics of the test groups: control; AT group, more
affected limb; and AT group, less affected limb.
AT more
p-value, AT less
p-value
Variable
Control
affected
C vs AT affected more vs less
14
14
[7 male]
[10 male]
0.26
Age (yrs)*
23.6±5.5
31.0±11.1
0.04
Height (m)
1.48±0.11
1.52±0.09
0.31
Weight (kg)*
67.4±13.0
87.7±21.3
0.01
Fat mass (%)
24.1(10.5) 27.5(11.2)
0.41
Lean mass (%)
72.3(9.3)
69.6(10.6)
0.48
BMI (kg·m ̄ ²)*
22.9±2.0
28.5±7.1
0.01
MAQ (met*hr/wk) 35.1(26.2) 59.6(53.6)
0.15
TSK
32.9(6.9)
36.6(9.7)
0.29
FAAMadl (%)*
99.2(1.6)
82.1(18.9)
0.005
§
VISA-A (%)*
99.2(2.9)
63.0(17.9)
<0.001
§
FAAMsport (%)*
98.1(3.0)
61.7(16.7)
<0.001
SLHR repetitions 58.5(35.6) 48.1(22.2)
0.40
§
*p<0.05 between groups; p<0.05 within AT group
n

-

-

93.3(10.9)
78.1(20.5)
86.5(14.2)
52.7(31.0)

0.07
0.048
<0.001
0.22

Fatigability: Single-Leg Hell Raise Test
Three participants (one control female, one AT female, one AT male) did
not complete the SLHR task. Therefore, results from this task are based on 13
control limbs, 12 AT limbs, and 12 AT control limbs. There were no differences in
SLHR repetitions completed between AT and control or the more and less
affected limbs in AT (Table 1).

Fatigability: Isometric Contractions
There were no differences in fatigability (i.e., the reduction in MVIC)
between groups, measured as the interaction between group and time (Figure
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4.2, p=0.936). There was no main effect of group on MVIC torque (p=0.096).
There was a significant main effect of time for all groups (p=0.001): increased
time in the fatiguing exercise task resulted in decreased MVIC torque for all
participants.

Figure 4.2. Fatigability (the reduction in MVIC across time) was not
different between groups (p=0.936). All groups demonstrated reduced MVIC
over time (p=0.001).

Voluntary Activation, and Resting Twitch Amplitude
The trends observed for the MVIC were similar for voluntary activation
(Figure 4.3): there were no interactions between group and time (p=0.866) and
no main effect of group (p=0.779), but there was a main effect of time (p=0.006);
increased time in the fatiguing task resulted in decreased voluntary activation for
both groups. In contrast, while there were no interactions between group and
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time for RT (p=0.637), there was a main effect of group (Figure 4.4, p=0.001): RT
torque was lower in AT at all time points compared to controls.
When comparing between limbs in people with AT, there were no
differences in any variables across time (interactions between limb and time:
MVIC: p=0.909; VA: p=0.937; RT: p=0.998). There were no main effects of limb
(more versus less affected limb in AT) on any of these variables (MVIC: p=0.226;
VA: p=0.773; RT: p=0.335). There was a main effect of time on all variables
(MVIC: p<0.001; VA: p=0.003; RT: p<0.001): increased time in the fatiguing task
resulted in similar between-limb reductions in MVIC and VA and similar changes
in RT.

Figure 4.3. All groups demonstrated reductions in neural drive over time
(p=0.006). The change in neural drive (quantified as Voluntary Activation using
the Interpolated Twitch Technique) was not different between groups (p=0.866).
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For all participants, RT increased between the start of the task and the
first minute (p<0.001), then decreased between minutes 1 and 4 (p<0.001).
There were no changes in RT between minutes 0 and 4. There was no
interaction between group and time (p=0.641).

Figure 4.4. RT was lower in AT compared to controls at all time points
(p=0.001). Collectively, the three groups experienced an increase in RT between
minutes 0 and 1 (p<0.001), followed by a decrease from minutes 1 to 4
(p<0.001). There was no change between minutes 0 and 4 (p=0.108). Analyzed
separately, from minutes 1 to 4, there was no change in RT in controls (p=0.185),
but a significant decrease in RT in both AT limbs (p<0.001). This difference was
different between controls and AT (p=0.003).

Pain
Pressure-pain thresholds (PPTs) measured at the upper trapezius were
larger in people with AT when compared to controls (Figure 4.5; interaction
between PPT location and group, p=0.011). PPTs were not different between
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groups when measured at the Achilles tendon (Figure 4.6; p=0.720) or medial
gastrocnemius (Figure 4.7; p=0.615). There was no influence of time on PPTs
(p=0.444): PPTs were not different between baseline and immediately following
the fatiguing exercise at any measurement location (medial gastrocnemius:
p=0.688; Achilles tendon: p=0.823; upper trapezius: p=0.856). Within the AT
group, there was no difference in PPTs between limbs when analyzed
collectively (p=0.695), and there were no interactions between limb, time, and
PPT location (p=0.609).
Baseline Achilles tendon pain (per the Numeric Pain Rating Scale, NPRS)
was not different between groups when assessed at rest (AT: 0.29(0.47);
Control: 0.00(0.00); p=0.228). Baseline calf pain (NPRS) also did not differ
between groups (AT: 0.00(0.00); Control: 0.29(0.73); p=0.308). Maximum calf
pain reported during fatiguing exercise was not different (AT: 3.2(2.5); Control:
2.5(3.1); p=0.145). However, the maximum Achilles tendon pain reported during
fatiguing exercise was greater in the more affected AT limb compared to controls
(AT: 1.57(1.74); Control 0.00(0.00); p<0.001). There were no differences
between the more and less affected limbs in the AT group, whether baseline calf
(AT Control: 0.00(0.00), p=1.0), baseline Achilles tendon (AT Control: 0.29(1.07),
p=1.0), maximum calf pain (AT Control: 3.4(2.8), p=0.833) or maximum Achilles
tendon pain experienced during the fatiguing exercise (AT Control: 1.3(1.6),
p=0.654). The maximum rating of perceived exertion (RPE) in the exercising calf
and tendon was not different between groups (AT: 7.3(3.0); Control: 8.1(2.2);
p=0.67) or within the tendinopathy group (AT Control: 7.3(2.9); p=1.0).
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Baseline upper trapezius PPT and maximum Achilles tendon pain (NPRS)
were positively correlated in the more affected limb in AT (r=0.559, p=0.058).
There was no relationship in the less affected limb in AT (r=0.104, p=0724) and
could not be computed in controls (Achilles tendon pain was 0 for all control
participants). Upper trapezius PPT was also positively correlated with medial
gastrocnemius PPT (r=0.867, p<0.001) and Achilles tendon PPT (r=0.747,
p=0.002) in AT. These correlations were not as strong in the less affected limb in
AT (medial gastrocnemius: r=0.816, p<0.001; Achilles tendon: r=0.700, p=0.005)
and were absent in controls (medial gastrocnemius: r=0.505, p=0.066; Achilles
tendon: r=0.518, p=0.058).
Baseline upper trapezius PPT and maximum reported Achilles tendon
pain (per NPRS) were used in mediation analyses, as these were the only pain
variables that differed between groups. Baseline upper trapezius PPT mediated
the relationship between group and the reduction in RT (r= -0.321, p=0.038):
greater upper trapezius PPT predicted greater reductions in RT torque between
minutes 1 and 4 of the fatiguing task. Baseline upper trapezius PPT did not
mediate the relationship between group and either the reduction in MVIC
(p=0.319) or the reduction in VA (p=0.989). Maximum Achilles tendon pain (per
NPRS) did not mediate the relationship between group and any of the outcome
measures: reduction in MVIC (p=0.308), change in RT (p=0.107), and reduction
in VA (p=0.524). When evaluated only in the people with AT (both limbs),
maximum reported Achilles tendon mediated the change in MVIC (r=-0.411,
p=0.030): higher upper trapezius pressure pain thresholds predicted greater
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reductions in RT torque, and higher perceived tendon pain predicted greater
reductions in MVIC torque.

Figure 4.5. Upper trapezius PPTs were higher in AT compared to controls at
all time points (p=0.011). Upper trapezius PPTs did not differ between limbs in
AT (p=0.919) and did not change following fatiguing isometric exercise (p=0.856).

Figure 4.6. Achilles tendon PPTs were not different between groups
(p=0.720) or between limbs (p=0.630). Achilles tendon PPTs did not change
across time (p=0.823)
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Figure 4.7. Medial gastrocnemius PPTs were not different between groups
(p=0.615) or between limbs (p=0.695). Medial gastrocnemius PPTs did not
change across time (p=0.618).

Predictors of Fatigability
The following variables were included in regression analyses to evaluate
the extent to which they predicted fatigability, measured as the reduction in MVIC
torque: maximum Achilles tendon pain during exercise (per NPRS); maximum
calf pain during exercise (per NPRS); pressure-pain thresholds (PPTs) at the
medial gastrocnemius, Achilles tendon, and upper trapezius; rating of perceived
exertion; change in voluntary activation; and change in resting twitch amplitude.
As a set, these variables predicted fatigability in the combined group of
participants (p=0.029). However, only the reduction in voluntary activation

103
predicted fatigability when considered in isolation (r=0.598, p<0.001). No other
variables predicted plantar flexor fatigability.
When the three groups were analyzed separately, the result was the
same: reduction in voluntary activation was the only variable to predict fatigability
(AT: r=0.586, p=0.028; control: r=0.607, p=0.021; AT Control: r=0.627, p=0.016).
While not significant, the relationship between change in voluntary activation and
RT differed in direction between groups: a negative relationship was found in the
more affected limb in AT (r= -0.373, p= 0.189), no relationship in the less affected
limb in AT (r= +0.061, p= 0.836), and a positive relationship was found in controls
(r= +0.209, p= 0.473). There was no relationship between the change in RT and
the change in MVIC for any of the groups (AT: r=0.271, p=0.348; Control:
r=0.386, p=0.173; AT Control: r=0.288, p=0.318).
When the three groups were analyzed together, there was a negative
correlation between baseline Achilles tendon PPT and the change in RT between
minutes 1 and 4 of isometric fatiguing exercise (r=-0.457, p=0.002). When the
three groups were analyzed separately, this relationship was absent in controls
and in the less-affected limb of AT (Control: r= -0.232, p=0.425; AT Control: r= 0.167, p=0.569). However, when the more affected limbs in AT were analyzed
alone, the relationship was strengthened (r= -0.782, p=0.001): larger pressurepain thresholds at the Achilles tendon predicted greater reductions in resting
twitch amplitude as a result of exercise.
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DISCUSSION

Summary of Findings
There were no differences in fatigability between AT and controls, whether
when measured using a common clinical test, the SLHR, or a laboratory-based
test of isometric fatiguing exercise. Voluntary activation, which is indicative of
neural drive, was the greatest predictor of fatigability from the isometric task in all
groups. Contractile function (RT torque) was reduced in the more affected limb in
AT compared to controls at all time points throughout the isometric fatiguing
contraction. Pain also differed between groups: perceived pain in the Achilles
tendon (per NPRS) was higher in the AT group; and central pain sensitivity was
lower (increased upper trapezius PPTs) in the AT group.

Fatigability
Fatigability was not different between groups or limbs, whether measured
as the acute reduction in MVIC following isometric exercise or for a dynamic task
as the number of repetitions completed in the SLHR.
Based on the findings from Aim 1, it is unsurprising that the SLHR did not
detect group differences. When implemented as in clinic, the SLHR has inherent
limitations that cannot be ignored. Not least of these is a questionable construct
validity (Hébert-Losier et al., 2009, Harris-Love et al., 2014). Future work should
address nuances of muscle function in the SLHR, including evaluating neural
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drive and contractile mechanisms related to task failure in people with AT
compared to healthy controls.
A recent case-control study evaluated strength and endurance in people
with AT (O'Neill et al., 2019). They reported impaired endurance of the plantar
flexor muscles in persons with AT. Their endurance task measured total work
performed during 20 repetitions of maximum-effort contractions. However, since
their AT group had decreased maximal plantar flexor strength at baseline, and
the study constrained number of repetitions to 20, the work performed by the AT
group would necessarily be lower. Importantly, this would not be the result of
worse endurance, but simply due to limited per-contraction force in the AT group
compared to healthy controls.

Reductions in Neural Drive and Contractile Function as Mechanisms of
Fatigability Voluntary activation decreased for all participants across the fatiguing
isometric task, indicating reduced neural drive, commonly termed central fatigue
(Gandevia, 2001). The magnitude of reduction in voluntary activation was
correlated with the magnitude of reduction in MVIC (fatigability), and this was
similar between groups.
People with AT had reduced resting twitch torque in their more affected
limb at all time points when compared to controls. All three groups demonstrated
an increase in RT between baseline and minute one of the fatiguing isometric
exercise. This increase in electrically-evoked torque was likely a result of the
stretch-shortening cycle effect, which has been demonstrated in response to
isometric contraction (Fukutani et al., 2015, Svantesson et al., 1994). After that
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time, RT remained unchanged in controls but decreased in both limbs in the AT
group. Thus, contractile function in both limbs in the AT group may have been
more affected by fatiguing exercise than controls.
Interestingly, in unilateral upper extremity tendinopathies, motor deficits
have been recorded in both upper extremities (Bisset et al., 2006). These
findings could explain why persons with AT had altered contractility of the triceps
surae muscles bilaterally.

Effect of Pain on Motor Output
Pain mediated the effect of diagnosis on motor output: presence of
tendinopathy alone did not predict group differences; instead, pain played a
mediating role in the effect of tendinopathy on motor output. Specifically, when
evaluated at a location remote from the Achilles tendon (the upper trapezius),
decreased sensitivity to painful stimuli (a higher PPT) correlated with greater
reductions in resting twitch amplitude. Similarly, larger pressure-pain thresholds
at the Achilles tendon predicted greater reductions in resting twitch amplitude
during fatiguing exercise. Greater reductions in MVIC (i.e., greater fatigability)
were correlated with higher perceived Achilles tendon pain during fatiguing
exercise.

A Comprehensive Look at Pain and Contractile Function in AT
People with AT had reduced resting twitch torque at all time points when
compared to controls. Resting twitch torque, a measure of involuntary torque
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production, decreased from the first to last minute in the fatiguing isometric
exercise task. This reduction was correlated with pain sensitivity both locally and
systemically (based on pressure-pain thresholds in the Achilles tendon and upper
trapezius, respectively): lower pain sensitivity was correlated with a greater
reduction in RT. In contrast, when people in the AT group experienced Achilles
tendon pain, it affected their maximal voluntary isometric strength: increased
perceived pain resulted in greater decrements in muscle force. However, the
decrements in force were not different from that demonstrated in the control
group.
The findings of this study suggest an unusual phenomenon in AT, a sort of
“inattention” to pain, perhaps enabled by central desensitization. Despite
impaired contractile mechanisms and Achilles tendon pain, people with AT
demonstrated similar exercise-induced reductions in torque as the controls and
similar neural drive. This may result from an ability to ignore the pain and tissue
damage, thanks to decreased pain sensitivity. It seems that these patients do not
consciously and voluntarily change their behavior based on pain. Rather,
involuntary processes may be responsible for the reduction in contractility,
perhaps in an effort to protect the injured tissue. Then, redistributing motor
command to agonist muscles (those not innervated by the tibial nerve) could help
reduce fatigue while enabling continued task performance (Blain et al., 2016,
Amann, 2012).
These unusual findings were specific to the AT group; no such
relationships existed in controls. The protective pain mechanisms that are
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expected to impede motor function during fatiguing exercise or with injury may
not be functioning in AT as they do in healthy controls. This, in turn, could help
explain chronicity in AT: continued activity participation could result from constant
re-injury to the already injured tendon. This could implicate an important role for
patient education and activity modification (Martin et al., 2018, Silbernagel et al.,
2007b). However, based on findings of central desensitization, reliance on
symptom monitoring may not be sufficient to protect the tendon from further
injury.

Limitations
This study utilized electrical stimulation of the tibial nerve for evaluation of
neural drive and contractile properties. The plantar flexors, however, receive
innervation from both the tibial and superficial fibular nerves. As such,
generalizability of findings from neural drive and contractile properties to reflect
function of all plantar flexor muscles is imperfect. However, under existing
methodology, it is both difficult and impractical to simultaneously stimulate both
motor nerves while avoiding stimulation of the antagonist muscles (the
dorsiflexors).
As in chapter 3, diagnosis was based on clinical presentation, not on
tendon quality as assessed using imaging. However, while imaging can assist in
diagnosing degeneration in the tendon (i.e., Achilles tendinosis) (Puddu et al.,
1976, Maffulli et al., 1998), tendon quality does not correlate well with symptoms
(Docking et al., 2015a, Kannus and Jozsa, 1991, van Dijk et al., 2011). In fact,
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tendon changes are correlated with age and BMI (Docking, 2021a, Kannus and
Jozsa, 1991). Therefore, degenerative changes would be more likely in the
tendinopathy group, which was older and heavier. Thus, any correlations
between symptom and tendon quality could be merely spurious and coincidental.
Despite attempts at matching based on age, body weight, and sex, the
control and AT groups were not matched. In order to address this, all measures
of MVIC torque and resting twitch torque were normalized to body weight. Also,
statistical analyses included covariates of age and sex. Heel raise repetitions
were not normalized to body weight. However, despite being heavier, the AT
group performed similarly in the SLHR task, suggesting that any normalization
would perhaps favor the AT group.

Conclusions
Fatigability was similar between people with AT and healthy controls,
whether when evaluated in response to a lab-based isometric fatiguing exercise
task or as number of repetitions performed in a dynamic clinical task, the SLHR.
In both groups, fatigability was predicted by neural drive. However, people with
AT had impaired muscle contractility, which – unlike in healthy controls – also
contributed to their fatigability. In people with AT, fatigability and muscle
contractile function were related to pain, suggesting an important role of pain in
mediating function in AT in both lower extremities. These findings suggest that a
comprehensive approach – involving activity modification and addressing pain
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and contractile function in the plantar flexors – may be necessary to resolve
symptoms and return these patients to their prior level of function.
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CHAPTER 5 : CONCLUSIONS & FUTURE DIRECTIONS
PURPOSE

The primary aims of this dissertation were to evaluate plantar flexor
muscle function, including strength, power, and fatigability, in people with
midportion Achilles tendinopathy (AT). This required first evaluating the validity
and utility of a common clinical test, the Single Leg Heel Raise (chapter 2). The
Single-Leg Heel Raise test (SLHR) was subsequently used in combination with
measures of maximal plantar flexor strength (both isometric and dynamic),
power, and isometric fatigability to evaluate differences in plantar flexor muscle
function between people with AT and healthy controls (chapters 3 and 4). Each
chapter evaluated the contributing role of neural drive and contractile
mechanisms on plantar flexor muscle function. As AT is a chronic condition
characterized by pain in the tendon, chapters 3 and 4 additionally evaluated pain
and its contributions to plantar flexor muscle function.

STRENGTH & FATIGABILITY BETWEEN GROUPS

Whether evaluated as maximal isometric or dynamic strength, isometric
fatigability, or dynamic fatigability, plantar flexor muscle function did not differ
between people with AT or healthy controls. Differences in maximal strength and
fatigability were also absent between limbs in people with AT: the more and less
affected limbs were equally strong and fatigable. These findings did not support
the hypotheses from Aims 2 and 3, which predicted worse strength and
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fatigability in the more affected limb when compared to either healthy controls or
the less affected limb.

THE SINGLE-LEG HEEL RAISE TEST

As was hypothesized in Aim 1, there was no relationship between
maximal isometric plantar flexor strength and performance in the SLHR,
measured as repetitions completed prior to task failure. Surprisingly, the SLHR
was also poorly associated with plantar flexor fatigability, measured as the acute
reduction in maximal plantar flexor force following the SLHR. Specifically, the
SLHR did not result in similar degrees of plantar flexor fatigability among
participants. Therefore, it was not surprising that SLHR performance was similar
between people with AT and healthy controls (chapter 4). These findings suggest
an important limitation in interpretation of SLHR performance, at least in regards
to its original design.
One limitation of the SLHR is its inability to truly isolate itself to plantar
flexor function. Certainly, no other muscles can perform the ankle plantar flexion
required to complete a heel raise. However, strength of intrinsic foot musculature
is critical to dynamic ankle function (Hashimoto and Sakuraba, 2014, McKeon et
al., 2015): the ability to translate forces across the talocrural joint into extension
at the metatarsophalangeal joints requires coordination with and stabilization of
the foot. Importantly, the ability to reach the terminal ankle flexion in a heel raise
requires ankle supination, and thus contributions from intrinsic and extrinsic
muscles of the foot and ankle. In one study, 36% of the variance in heel raise
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height was attributed to midfoot peak power (DiLiberto and Nawoczenski, 2020),
suggesting an important limitation in attributing SLHR performance to plantar
flexor function alone.
In contrast to the SLHR, laboratory-based measures of muscle function
can often be isolated to specific joint regions. For example, when testing maximal
strength in a laboratory setting, constraints are often applied to neighboring joint
regions. This limits the contributions being made by other muscle groups.
Importantly, it restricts participants from using compensatory behaviors to
achieve a task. As such, performance can be attributed directly to the joint region
of interest. The SLHR requires the participant to independently stabilize
neighboring joint regions and thus does not share this same advantage.
The mean number of repetitions completed by healthy control participants
was similar to that reported in a study evaluating normative SLHR in healthy
controls (Hébert-Losier et al., 2017). This study also developed models to
estimate the number of heel-raise repetitions expected by biological sex and
decade of life, assuming a BMI of 24.2 and a moderate physical activity level.
Based on this model, the median number of heel-raise repetitions completed by
males in chapter 2 (Aim 1) were similar to that estimated for young males in their
second decade. However, the range of heel-raise repetitions completed by young
females in chapter 2 was higher than that estimated by the model for females in
their second decade. However, this difference may be attributed to a slightly
lower BMI among participants in chapter 2 or possible differences in physical
activity levels between these cohorts.
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SEX DIFFERENCES IN PLANTAR FLEXOR FUNCTION

Male sex has been identified as an intrinsic risk factor for developing AT
(Magnan et al., 2014). The rationale for sex differences in AT, however, is poorly
understood. This dissertation sought to first investigate sex differences in plantar
flexor function in healthy controls (Aim 1), as this could contribute to possible sex
differences in plantar flexor function in AT. Isometric plantar flexor strength and
performance in the SLHR did not differ between healthy males and females
(chapter 2). Similarly, comparisons in plantar flexor function between people with
AT and healthy controls were not different when controlling for sex. If prevalence
of AT indeed differs between males and females, whereby males are more
frequently affected (Joseph et al., 2014, Kvist, 1991) – a notion debated among
clinicians and researchers (Albers et al., 2016, Hopkins et al., 2016), the findings
of this dissertation suggest that this would not be the result of differences in
plantar flexor function. However, it is important to consider that Aims 2 and 3
studies lacked sufficient power to empirically evaluate sex differences in plantar
flexor function among persons with AT.

BILATERAL CHANGES IN MUSCLE FUNCTION IN AT

It is interesting to note that, in contrast to the hypotheses in Aims 2 and 3,
people with AT had similar muscle function in both limbs. Such bilateral motor
and sensory changes in unilateral tendinopathies have been reported previously
(Heales et al., 2014). While the results of this dissertation support the findings in
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the systematic review completed by Heales et al. (2014), however, caution must
be taken when interpreting between-limb differences as reported in chapters 3
and 4. Specifically, the “control” limb in people with AT was asymptomatic in only
50% of the participants. In the other half of AT participants, the “control” limb was
simply less affected than the test limb. As such, the data from participants with
bilateral tendinopathy symptoms may have contaminated the between-limb
results in people with AT. Nevertheless, tendon pathology is common in the
contralateral, asymptomatic limb of unilateral AT (Docking et al., 2015b, Rabello
et al., 2020), so even an AT cohort that was purely unilateral in symptoms could
have presented with heterogeneity in muscle function and pain.

NEURAL DRIVE AND CONTRACTILE FUNCTION

Neural drive to the plantar flexor muscles did not differ between groups in
any Aims of this dissertation. In Aim 1 (chapter 2), males and females had similar
reductions in neural drive following the SLHR, and this was associated with
fatigability from the task. The hypotheses in Aim 1 were supported by this finding.
In Aims 2 and 3 (chapters 3 and 4), people with AT and healthy controls had
similar neural drive at baseline and in response to fatiguing exercise. As in Aim 1,
neural drive predicted fatigability in Aim 3, and it was the only predictor of
fatigability in all three groups (more and less affected limbs in AT and healthy
controls.
Despite similar plantar flexor strength and fatigability and similar neural
mechanisms, contractile function differed between groups: compared with
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controls, people with AT had decreased resting twitch amplitudes at rest in their
more affected limbs (chapter 3). These differences in contractile function,
however, were not accompanied by differences in maximal isometric strength
between groups. Instead, the contributions of neural and contractile mechanisms
differed between people with AT and healthy controls: in controls, maximal
strength was predicted by neural drive but not by contractile function; in the more
affected limb in AT, maximal strength was predicted by contractile function, but
not by neural drive; and in the less affected limb in AT, maximal strength was
predicted by a combination of neural drive and contractile function.
People with AT also experienced reductions in resting twitch amplitudes in
response to fatiguing isometric exercise (chapter 4). Interestingly, the fatiguing
exercise resulted in reductions in resting twitch amplitudes in both limbs in
people with AT. These remained unchanged in healthy controls. This suggests
deficits within the contractile mechanisms in both limbs of people with AT.
However, the reduction in resting twitch amplitude was not related to the
reduction in maximal strength (fatigability). These findings suggest an impairment
within the triceps surae muscles (impaired contractile function) that may be
compensated for by other plantar flexor muscles. This type of compensation
would enable people with AT to demonstrate similar external torque production
as healthy controls, despite decreased contribution of the triceps surae in
generating internal force.
An alternate explanation for differences in resting twitch amplitude in AT
(both at baseline and in response to fatiguing exercise) despite similar maximal
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strength measures relates to tendon elasticity. Elasticity of tendon is predicted
using the linear region of a stress-strain curve, which depicts the relationship
between force applied on a tendon and the resulting tissue deformation (Kelc et
al., 2013). The Achilles tendon is less stiff (i.e., more elastic) in people with AT
(Finnamore et al., 2019, Morgan et al., 2018). Perhaps the reduction in stiffness
is not readily apparent during maximal contractions, as the muscle-generated
force would be high enough to bring the tendon into the linear region of the
stress-strain curve. Resting slack in the tendon, known as the toe region, would
be fully taken up as the collagen fibrils uncrimp (Kelc et al., 2013). However, in
contrast to maximal contraction, resting twitch amplitudes occur at around 20% of
the maximal isometric torque. As such, it is conceivable that this level of force is
insufficient to bring the tendon out of the toe region and into the linear region of
the stress-strain relationship, thereby resulting in reduced force propagation from
the muscle through the tendon and, therefore, reduced external torque
generation. Analysis of tendon elasticity – and evaluation of whether this
correlates with reduced resting twitch amplitudes in AT – would help elucidate
whether this is the case. If so, resting twitch amplitudes could prove to be
beneficial when quantifying tendon elasticity in this clinical population, particularly
as a way to translate changes in tendon elasticity into a clinically relevant,
functional outcome measure (namely, joint forces).
The studies contained within this dissertation used resting twitch
amplitude to evaluate contractile properties. However, there are many additional
variables related to resting electrical stimulation that may be of interest, such as
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rate of force development, rate of force relaxation, and changes in muscle activity
(as measured using electromyography). Analyzing these additional variables may
provide further understanding of differences in maximal strength and fatigability
between groups.

PAIN AND ITS INTERACTIONS WITH MUSCLE FUNCTION IN AT

People with AT had decreased central pain sensitivity: upper trapezius
pressure-pain thresholds (PPTs) were higher in people with AT compared to
healthy controls (chapter 3). Furthermore, in people with AT, lower baseline pain
sensitivity was associated with greater reductions in contractile properties: those
with higher pressure-pain thresholds at the upper trapezius and Achilles tendon
had greater reductions in resting twitch amplitude with fatiguing exercise (chapter
4). These findings, though counter-intuitive, may implicate pain desensitization as
a perpetuating factor in AT chronicity. It is conceivable that decreased pain
sensitivity enables continued participation in motor tasks, even if those same
tasks result in further damage to the musculotendinous unit. If this were the case,
greater degrees of tissue damage (in this case, measured by impaired contractile
function) would be associated with decreased pain sensitivity. Though
theoretical, this idea supports the relationship between decreased pain sensitivity
and impaired contractile function observed in this dissertation (chapter 4). As
addressed in chapter 3, however, the unusual pressure-pain threshold results
could simply be the result of a heavier AT group comprised of more males than
the control group.
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Despite the inverse – and somewhat counterintuitive – relationship
between pain sensitivity (PPT) and contractile function, Achilles tendon pain (per
NPRS) was positively correlated with fatigability in people with AT. Among
people with AT, those who reported higher levels of Achilles tendon pain from
fatiguing exercise also demonstrated greater reductions in maximal torque
(fatigability). However, the magnitude of fatigability was not different from healthy
controls. Thus, despite greater maximum tendon pain predicting greater
fatigability, people with AT, on average, performed similarly to healthy controls
during fatiguing isometric exercise.
Decreased pain sensitivity predicted greater reductions in contractile
function, while increased pain predicted greater fatigability. However, the change
in MVIC (degree of fatigability) was not correlated with the change in resting
twitch amplitude (contractile function), nor was pain sensitivity correlated with
fatigability. Definitive statements about the underlying processes cannot be made
based on results of this dissertation alone. The relationship between Achilles
tendon pain (NPRS) and fatigability implies that a symptom monitoring approach
could be beneficial in people with AT. Yet, decreased sensitivity to pain (PPT)
and its correlation to impaired contractility suggest that that symptom monitoring
alone is insufficient. Similarly, tracking motor performance alone is likely
insufficient; impairments in contractile function did not translated into increased
fatigability in people with AT.
When considering each of these variables – pain sensitivity (PPT), tendon
pain (NPRS) resulting from fatiguing exercise, contractile function, and fatigability

120
– and the relationships between them, the impact of pain on motor function in AT
is complex. Only when the patient recognizes pain – as evidenced by selfreported pain on the NPRS – do they modify their voluntary behavior (as
evidenced by greater reductions in MVIC). Yet, impairments in contractile
function underly their motor performance. The theory of motor adaptation posed
by Hodges (2011) may explain the seeming inconsistencies within these findings
(Hodges, 2011). Using this theoretical framework, redistribution of muscle activity
would be warranted to protect the injured tendon. By redistributing motor
commands to agonist plantar flexor muscles (namely, the fibularis muscles,
innervated by the superficial fibular nerve), the body could optimize motor output,
despite impairments in contractile function in the muscles innervated by the tibial
nerve.
Ultimately, the findings from this dissertation identify a complicated
interaction between motor function and pain in persons with AT: limitations in
contractile function do not necessarily result in appreciable differences in plantar
flexor strength and fatigability, and perceived pain in the tendon does not predict
reductions in contractile function. Furthermore, it is unclear whether adaptations
in motor function are due to pain or whether they precede pain in people with AT.
Either way, these long-term changes in motor function could prove detrimental to
symptoms and function if not addressed with appropriate interventions. If
redistribution of motor activity (Hodges, 2011) explains these changes, it may
also be the key to effective and efficient treatment in AT. Certainly, symptoms
and muscle function are important outcomes to monitor during clinical
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management in AT. However, rather than prioritizing improvements in force,
power, or fatigability, the muscle parameter of interest may actually be motor
control.

LIMITATIONS

An important limitation in each aim relates to study power and the number of
participants; each study included only 14 participants per group. As such, the
ability to detect small, between-group differences was limited. Importantly,
insufficient statistical power can lead to type II error: concluding there are not
group differences when differences indeed exist (Schreffler 2020). In contrast,
the risk of type I error (false positive, or concluding there are not group
differences when differences indeed exist) is a risk associated with very large
sample sizes.
An additional limitation of this study relates to multiple comparisons. By
virtue of the large number of variables being analyzed – and for such a small
sample size – there is a risk of inflating type I error (falsely concluding there are
group differences when differences do not exist). However, many of the variables
presented in this thesis were not different between-groups. As explained above,
this could have resulted from insufficient power to detect group differences. Of
those variables that were different between groups, the effect sizes, calculated
as Cohen’s d, exceeded 0.74: baseline resting twitch amplitude, d=0.824,
power=0.987; baseline upper trapezius PPT, d=0.748, power=0.967; post-task
upper trapezius PPT, d=0.787, power=0.979.
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A recent study recommended subgroupings of patients with AT in an effort to
identify heterogeneity among persons with AT (Hanlon et al., 2021). These
groupings were as follows: activity-dominant, psychosocial-dominant, and
structure-dominant. The participants included in aims 2 and 3 were perhaps most
representative of the activity-dominant subgroup – a group characterized by their
young age, continued high activity levels, and mild symptoms. As a result, the
findings may not translate to the entire population of persons with AT, but rather
primarily the subgrouping of activity-dominant AT patients.

SUMMARY

This body of work has contributed to the field in several important ways: by
describing neuromuscular function of the plantar flexor muscles during a
common clinical evaluation tool, the Single-Leg Heel Raise test; by evaluating
neuromuscular function of the plantar flexor muscles in people with AT; and by
combining measures of pain alongside measures of motor function in people with
AT. Importantly, many of the tools and techniques utilized in these studies have
not been previously utilized in people with AT or as they relate to performance in
the Single-Leg Heel Raise test. Future work should focus on additional
evaluation of neuromuscular function in AT, including: during other forms of
fatiguing exercise; alongside evaluation of tendon elasticity; and by evaluating
additional properties of contractile function, such as rate of torque development
and relaxation. Finally, future work should take into consideration both the
subgroupings that may exist within AT and the importance of sufficient sample
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size to enhance study power, both of which will contribute to greater external
validity of future research studies.
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